NCT_id,matched_string,manual_string,criteria_string,parent_concept_id,parent_concept_name,w.mod,severity_modifier,severity_term,pre_post,snomed_id,snomed_name,
NCT03937804,scoliosis,kyphoscoliosis,"ve pulmonary disease, chronic obstructive airway disease, emphysema, chronic bronchitis, lung transplant, kyphoscoliosis, sarcoidosis, bronchopulmonary dysplasia, cystic fibr",72418,Scoliosis deformity of spine,FALSE,unmarked,,,405773007,Kyphoscoliosis deformity of spine (disorder),
NCT00252252,scoliosis,scoliosis,"ar disease (eg. old polio, bilateral diaphragm
             paralysis) or chest wall disease (eg. idiopathic scoliosis, thoracoplasty)

          -  Recruited from 1300 patients attending Royal Brompt",72418,Scoliosis deformity of spine,FALSE,unmarked,,,203639008,Idiopathic scoliosis (disorder),
NCT03329716,scoliosis,scoliosis,"en wearing underarm (Boston) bracing, and who have reached
             skeletal maturity based on the Scoliosis Research Society (SRS) standardized criteria:
             Risser stage ≥4, >2 years po",72418,Scoliosis deformity of spine,FALSE,N/A,,,N/A,N/A,
NCT03090971,scoliosis,scoliosis,"a distinct osseous lesion, such as sphenoid wing dysplasia, pseudoarthrosis of the
             tibia, macrocephaly, or scoliosis

          -  a first-degree relative with NF1

          -  Presen",72418,Scoliosis deformity of spine,FALSE,unmarked,,,298382003,Scoliosis deformity of spine (disorder),
NCT03404232,scoliosis,scoliosis,"pine

          -  Relevant peripheral neuropathy

          -  Acute denervation subsequent to a radiculopathy

          -  Scoliosis with Cobb angle greater than 25°

          -  Spondylolisthesis",72418,Scoliosis deformity of spine,FALSE,unmarked,,,298382003,Scoliosis deformity of spine (disorder),
NCT01467882,scoliosis,severe scoliosis," or other study endpoints (e.g. chronic steroid use [except mild topical steroids],
             renal failure, diabetes, moderate to severe scoliosis, previously treated intracranial
             tum",72418,Scoliosis deformity of spine,TRUE,severe,severe,post,37394658,Severe sepsis,
NCT03581084,scoliosis,severe scoliosis,"tis, vocal cord dysfunction
             (that is the sole cause of respiratory symptoms and at the PI's discretion), severe
             scoliosis or chest wall deformities that affect lung function,",72418,Scoliosis deformity of spine,TRUE,severe,severe,post,37394658,Severe sepsis,
NCT01926275,scoliosis,severe kyphoscoliosis,"nced
             bronchiectases, active tuberculosis, post tuberculosis syndrome, pneumonia, severe
             kyphoscoliosis, tracheostoma, neuromuscular diseases, or any other disorder, which
   ",72418,Scoliosis deformity of spine,TRUE,severe,severe,post,443531,Kyphoscoliosis deformity of spine (disorder),
NCT01784094,scoliosis,scoliosis,":

          -  previous severe back or lower extremity injury or surgery

          -  major structural spinal deformity (scoliosis, kyphosis, stenosis)

          -  ankylosing spondylitis or rheuma",72418,Scoliosis deformity of spine,TRUE,unmarked,,,298382003,Scoliosis deformity of spine (disorder),
NCT02131090,scoliosis,scoliosis,"men

          -  BMI < 50

        Exclusion Criteria:

          -  BMI >50

          -  Documented diagnosis of scoliosis and/or other significant lumbar spinal pathology

          -  Previous lu",72418,Scoliosis deformity of spine,TRUE,unmarked,,,298382003,Scoliosis deformity of spine (disorder),
NCT02081430,muscle wasting,muscle wasting,"nce of central nervous system involvement such as exaggerated reflexes, changes
             in sensation in the hands, muscle wasting in the hands, impaired sensation of the
             face, altere",78236,Muscle atrophy,FALSE,unmarked,,,88092000,Muscle atrophy (disorder),
NCT01571674,muscle wasting,muscle wasting," of central nervous system involvement, to include hyperreflexia, sensory
             disturbances in the hand, intrinsic muscle wasting of the hands, unsteadiness during
             walking, nystag",78236,Muscle atrophy,FALSE,unmarked,,,88092000,Muscle atrophy (disorder),
NCT03078543,muscular atrophy,muscular atrophy,"ct has conditions that may interfere with the TKA survival or outcome (e.g.
             Paget's or Charcot's disease, vascular insufficiency, muscular atrophy, uncontrolled
             diabetes mell",78236,Muscle atrophy,FALSE,unmarked,,,88092000,Muscle atrophy (disorder),
NCT02668835,muscular atrophy,progressive muscular atrophy,"e - Multiple sclerosis, amyotrophic lateral sclerosis, motor
             neuritis, progressive bulbar palsy, progressive muscular atrophy, spinal muscular
             atrophy

          -  Significa",78236,Muscle atrophy,FALSE,unmarked,,,88923002,Progressive muscular atrophy (disorder),
NCT03981575,muscle wasting,muscle wasting,"udy:

          -  Known CTG repeat expansion size less than 100 repeats, unless there are clear cut
             signs of limb weakness and muscle wasting. This is in order to obtain a muscle tissue
",78236,Muscle atrophy,FALSE,unmarked,,,88092000,Muscle atrophy (disorder),
NCT00394043,muscle atrophy,muscle atrophy,"atency greater than
             0.2 ms

        Exclusion Criteria:

          -  severe CTS that has progressed to muscle atrophy

          -  pregnancy

          -  previous wrist surgery on the ",78236,Muscle atrophy,TRUE,unmarked,,,88092000,Muscle atrophy (disorder),
NCT03424707,muscular atrophy,muscular atrophy,"g confirmed
             degenerative spondylosis, severe arthritis or severe osteoporosis) (2) myositis,
             muscular atrophy, myotonia, myasthenia (3) peptic ulcer or duodenal ulcer (4)
   ",78236,Muscle atrophy,TRUE,unmarked,,,88092000,Muscle atrophy (disorder),
NCT02741076,amyotrophy,diabetic amyotrophy,"on, severe or progressive lower extremity weakness or numbness, bowel or
             bladder dysfunction as a result of cauda equina compression, diabetic amyotrophy,
             meningitis, diskiti",78236,Muscle atrophy,TRUE,unmarked,,,39058009,Lumbosacral radiculoplexus neuropathy co-occurrent and due to diabetes mellitus (disorder),
NCT03517319,muscle atrophy,muscle atrophy,"fore screening

          -  history or plan for tendon lengthening surgery

          -  significant contracture or muscle atrophy at the target joint or muscle

          -  concurrent treatment with",78236,Muscle atrophy,TRUE,unmarked,,,88092000,Muscle atrophy (disorder),
NCT01427361,muscular atrophy,muscular atrophy," Exclusion Criteria:

          1. Patient with infection or sepsis.

          2. Patient with any vascular insufficiency, muscular atrophy, or neuromuscular disease
             severe enough to com",78236,Muscle atrophy,TRUE,unmarked,,,88092000,Muscle atrophy (disorder),
NCT00692172,systemic infection,systemic infection,"al hematology values or history of an immunosuppressive
             disorder

          -  Serious local infection or systemic infection within 3 months prior to the first dose
             of alefac",132797,Sepsis,FALSE,unmarked,,,91302008,Sepsis (disorder),
NCT01865708,sepsis,urosepsis,"n applicable) consent for enrollment.

        Exclusion Criteria:

          -  18 yo or older.

          -  Urosepsis at time of study enrollment

          -  Known bladder or genitourinary abnorm",132797,Sepsis,FALSE,unmarked,,,721104000,Sepsis due to urinary tract infection (disorder),
NCT02370160,systemic infection,systemic infection,"r infectious pulmonary parenchymal disease

          -  Presence of active CNS leukemia

          -  Presence of any uncontrolled systemic infection

          -  Documented uncontrolled seizure dis",132797,Sepsis,FALSE,unmarked,,,91302008,Sepsis (disorder),
NCT03737929,sepsis,sepsis,"    -  Contra-indication to transoesophageal echocardiogram (TEE)

          -  Carotid stenosis > 80%,

          -  Active infection or sepsis

          -  Pleural adhesions,

          -  Elevated",132797,Sepsis,FALSE,unmarked,,,91302008,Sepsis (disorder),
NCT02304978,sepsis,severe sepsis,"able angina or myocardial infarction in the acute phase (not older
             than two months)

          -  Severe sepsis (hospitalization)

          -  Cirrhosis stage Child C

          -  Chron",132797,Sepsis,FALSE,severe,severe,pre,1036671000000100,Severe sepsis,
NCT01543022,systemic infection,systemic infection," that will preclude insertion of the Symphony
             device.

         10. Moderate to severe aortic insufficiency (2+ or more).

         11. Ongoing systemic infection defined as two of the fo",132797,Sepsis,TRUE,unmarked,,,91302008,Sepsis (disorder),
NCT00758862,systemic infection,systemic infection,"        Exclusion Criteria:

          -  Immunosuppressed state or other serious systemic disease

          -  Signs and/or symptoms of systemic infection, such as malaise and fever or local
       ",132797,Sepsis,TRUE,unmarked,,,91302008,Sepsis (disorder),
NCT03230916,sepsis,severe sepsis," been discontinued, or has received
             REL for any other reason.

          -  Has a current diagnosis of cystic fibrosis, meningitis, or severe sepsis.

          -  Is expected to survive ",132797,Sepsis,TRUE,severe,severe,pre,1036671000000100,Severe sepsis,
NCT01687166,sepsis,sepsis,"nths) prior to enrollment

          -  Left atrial appendage closure device

          -  Any other significant uncontrolled or unstable medical condition (e.g. sepsis, acute
             metabolic i",132797,Sepsis,TRUE,unmarked,,,91302008,Sepsis (disorder),
NCT01078610,sepsis,sepsis," the drug or one of the other ingredients

          -  Active tuberculosis or other severe infections (e.g. sepsis and opportunistic
             infections)

          -  Moderate to severe cardiac ",132797,Sepsis,TRUE,unmarked,,,91302008,Sepsis (disorder),
NCT02432638,cleft palate,cleft palate,"will include all infants regardless of syndromic diagnosis, other organ
             system abnormalities, cleft palate diagnosis or the presence of other concurrent
             craniofacial anomalie",135923,Cleft palate,FALSE,unmarked,,,87979003,Cleft palate (disorder),
NCT03366740,cleft palate,cleft lip and cleft palate,"     ICU support during the admission

          -  Birth defect like complex congenital heart diseases, cleft lip and cleft palate, Down
             syndrome and cerebral palsy and others that may i",135923,Cleft palate,FALSE,unmarked,,,66948001,Cleft palate with cleft lip (disorder),
NCT02858388,cleft palate,cleft lip and cleft palate,"sion Criteria:

          1. Outcomes of adenotonsillectomy

          2. Velo-palatal insufficiencies, cleft lip and cleft palate.

          3. Hearing loss of perceptual, and mixed type.

         ",135923,Cleft palate,FALSE,unmarked,,,66948001,Cleft palate with cleft lip (disorder),
NCT00422981,cleft palate,cleft palate,"harynx, except for surgical correction of the nasal septum or a ""broken
             nose"" at least 2 years previously, or surgical repair of cleft palate when <30 years
             of age.

        ",135923,Cleft palate,FALSE,N/A,,,N/A,N/A,
NCT04023825,cleft palate,cleft palate,"-  children between 5 months and 12 years old

          -  weight >5kg

          -  children undergoing cleft palate repair surgery with or without upper lip surgery

        Exclusion Criteria:

  ",135923,Cleft palate,FALSE,N/A,,,N/A,N/A,
NCT02435407,cleft palate,cleft palate,"ly significant)

        Exclusion Criteria:

          -  •A child who has an anatomical cause for feeding problems such as cleft palate or
             significant oromotor abnormality

            ",135923,Cleft palate,TRUE,unmarked,,,87979003,Cleft palate (disorder),
NCT01021397,cleft palate,cleft palate,"d
             topical antifungal agents are not excluded.

          -  Major congenital malformations, including congenital cleft palate, cytogenetic
             abnormalities, or serious chronic d",135923,Cleft palate,TRUE,unmarked,,,87979003,Cleft palate (disorder),
NCT02975310,cleft palate,cleft palate," not be able to complete the follow-up appointments/evaluations

          6. Have significant oral structural abnormalities, e.g. unrepaired cleft palate

          7. Septal deviation requiring corr",135923,Cleft palate,TRUE,unmarked,,,87979003,Cleft palate (disorder),
NCT03236194,cleft palate,cleft palate," a congenital anomaly or neonatal condition that significantly affects a
             newborn's feeding (e.g. cleft lip, cleft palate, metabolic disease)

          4. any major maternal morbidities a",135923,Cleft palate,TRUE,unmarked,,,87979003,Cleft palate (disorder),
NCT01623310,cleft palate,cleft palate,"onths before the screening visit

          -  Current, ongoing rhinitis medicamentosa (rebound rhinitis)

          -  Have significant oral structural abnormalities, eg, a cleft palate

          - ",135923,Cleft palate,TRUE,unmarked,,,87979003,Cleft palate (disorder),
NCT00766818,hypothyroidism,hypothyroidism,"tra® component

          -  Chronic hepatitis B and/or C virus infection

          -  Cushing's Syndrome

          -  Untreated hypothyroidism or hyperthyroidism

          -  Serum Creatinine > 1.",140673,Hypothyroidism,FALSE,unmarked,,,40930008,Hypothyroidism (disorder),
NCT02607254,hypothyroidism,hypothyroidism,"             symptomatic peripheral vascular disease including intermittent claudication,
             pernicious anemia, untreated hypothyroidism, venous insufficiency, or spinal stenosis.

         ",140673,Hypothyroidism,FALSE,unmarked,,,40930008,Hypothyroidism (disorder),
NCT02895087,hypothyroid,hypothyroidism," sleep disorder, Addison's disease, diabetes or thyroid/pituitary/adrenal/splenic
             disorder (note: corrected hypothyroid disorder may be allowed if recent Thyroid
             Stimulating ",140673,Hypothyroidism,FALSE,unmarked,,,40930008,Hypothyroidism (disorder),
NCT02023554,hypothyroidism,hypothyroidism,"h renal or hepatic dysfunction;

          -  patients with congestive heart failure;

          -  patients with hypothyroidism or hyperthyroidism;

          -  patients taking drugs likely to affec",140673,Hypothyroidism,FALSE,unmarked,,,40930008,Hypothyroidism (disorder),
NCT03817125,hypothyroidism,hypothyroidism,"trictive procedures such as
             banding, are permitted).

          7. Any diagnosis of autoimmune disease. Participants with Type I diabetes mellitus,
             hypothyroidism only requir",140673,Hypothyroidism,FALSE,unmarked,,,40930008,Hypothyroidism (disorder),
NCT02532335,hypothyroidism,hypothyroidism,"el surgery

        Inflammatory bowel disease

        Uncontrolled diabetes mellitus (fasting blood glucose >6.7 mmol/L), hypothyroidism or
        hyperthyroidism, or other significant endocrine di",140673,Hypothyroidism,TRUE,unmarked,,,40930008,Hypothyroidism (disorder),
NCT00796783,hypothyroidism,signficant hypothyroidism,"           as those with severe obesity, major depression or a history of alcoholism.

          -  Uncontrolled, clinically significant hypothyroidism or hyperthyroidism.

          -  Have renal fai",140673,Hypothyroidism,TRUE,severe,significant,,40930008,Hypothyroidism (disorder),
NCT01140997,hypothyroidism,,"rocess, history of
             significant pulmonary disease or any history of interstitial lung disease.

          -  History of hypothyroidism or current treatment for thyroid disease.

          ",140673,Hypothyroidism,TRUE,,,,,,
NCT03379012,hypothyroidism,,"er; 5. Normal PSA level

        Exclusion Criteria:

          1. Prostate and other cancers history

          2. Hypothyroidism

          3. History of serious cardiac arrhythmia, congestive heart",140673,Hypothyroidism,TRUE,,,,40930008,Hypothyroidism (disorder),
NCT01167127,hypothyroidism,,"th hypoxia and/or hypercapnia, severe obstructive pulmonary disease, cor
             pulmonale, severe bronchial asthma, paralytic ileus.

         15. Patients with myxodema, hypothyroidism, Addison",140673,Hypothyroidism,TRUE,,,,40930008,Hypothyroidism (disorder),
NCT03595553,diarrhea,," of age, at the time of signing the informed consent.

          2. Signs and symptoms of CDI including diarrhea such that in the Investigator's opinion
             CDI antimicrobial therapy is requi",196523,Diarrhea,FALSE,,,,5.891E+12,Clostridium difficile diarrhea (disorder),
NCT00998296,diarrhoea,,"   1. Active infectious disease

          2. Recent surgery within the last 4 weeks prior visit 1.

          3. Chronic diarrhoea or gastrointestinal tract disease resulting in an inability to take
",196523,Diarrhea,FALSE,,,,236071009,Chronic diarrhea (disorder),
NCT03833700,diarrhea,,"      6. Inability to take oral medication, or malabsorption syndrome or any other uncontrolled
             gastrointestinal condition (example: nausea, diarrhea, or vomiting) that might impair
     ",196523,Diarrhea,FALSE,,,,62315008,Diarrhea (finding),
NCT00275704,diarrhea,,"levels and might have additive effects
             when used with antidiabetic drugs).

          -  Diagnosis of/problems with chronic diarrhea or history of bowel obstruction or
             esopha",196523,Diarrhea,FALSE,,,,236071009,Chronic diarrhea (disorder),
NCT00563823,diarrhea,," limited to, any of the following
             conditions:

               -  Ulcerative disease

               -  Uncontrolled nausea

               -  Vomiting

               -  Diarrhea which mi",196523,Diarrhea,FALSE,,,,62315008,Diarrhea (finding),
NCT03739931,diarrhea,,"ongestive heart failure, uncontrolled hypertension, unstable
             angina pectoris, cardiac arrhythmia, ILD, serious chronic gastrointestinal conditions
             associated with diarrhea, o",196523,Diarrhea,TRUE,,,,62315008,Diarrhea (finding),
NCT00295607,diarrhoea,,"ngoing corticosteroid therapy.

          -  Patient has significant, uncontrolled concomitant infections and/or severe diarrhoea,
             vomiting, active upper gastro-intestinal tract malabsorp",196523,Diarrhea,TRUE,,,,409587002,Severe diarrhea (finding),
NCT03111511,diarrhea,,"             Disease [MDRD] formula12), significant cardiac, vascular, pulmonary, gastrointestinal
             (such as significant diarrhea, gastric stasis, or constipation that in the
             ",196523,Diarrhea,TRUE,,,,62315008,Diarrhea (finding),
NCT00183248,diarrhea,,"     3 times the upper value of the normal range within 28 days prior to study entry

          -  Uncontrolled concomitant infections, severe diarrhea, vomiting, active upper
             gastrointes",196523,Diarrhea,TRUE,,,,409587002,Severe diarrhea (finding),
NCT00540592,diarrhoea,," a
             moderate or severe illness with or without fever. All vaccines can be administered to
             persons with a minor illness such as diarrhoea, mild upper respiratory infection with",196523,Diarrhea,TRUE,,,,62315008,Diarrhea (finding),
NCT03378999,chronic obstructive pulmonary disease,,"al conditions that might interfere with the study, such as epilepsy,
             asthma, kidney failure or renal insufficiency, chronic obstructive pulmonary disease,
             inflammatory bowel ",255573,Chronic obstructive lung disease,FALSE,,,,13645005,Chronic obstructive lung disease (disorder),
NCT03131752,chronic obstructive lung disease,,"h genders, who are in a an exacerbation of the
             disease according to Global Initiative for Chronic Obstructive Lung Disease
             (GOLD,2015) refered by the doctors, hospitalized or",255573,Chronic obstructive lung disease,FALSE,,,,N/A,N/A,
NCT00605891,chronic obstructive lung disease,,"ional Heart Lung and Blood Institute/World Health Organization (NHLBI/WHO) Global
             Initiative for Chronic Obstructive Lung Disease (GOLD)

          -  Patient meets the following requirem",255573,Chronic obstructive lung disease,FALSE,,,,N/A,N/A,
NCT00137007,chronic obstructive pulmonary disease,,"         -  Bronchiectasis, bronchial obstruction or history of post-obstructive pneumonia
                  (this does not exclude patients with chronic obstructive pulmonary disease);

             ",255573,Chronic obstructive lung disease,FALSE,,,,N/A,N/A,
NCT02671942,chronic obstructive pulmonary disease,,"   .(postbronchodilator ≤0.7,，and a postbronchodilator FEV1≤50% predicted);

          3. Has a history of chronic obstructive pulmonary disease (COPD) (according to Global
             Initiative for",255573,Chronic obstructive lung disease,FALSE,,,,N/A,N/A,
NCT03794856,chronic obstructive pulmonary disease,," cord dysfunction (identified by abnormalities in spirometric
             flow-volume curves), clinically significant chronic obstructive pulmonary disease, or
             emphysema.

          -  P",255573,Chronic obstructive lung disease,TRUE,,,,13645005,Chronic obstructive lung disease (disorder),
NCT03919422,chronic obstructive pulmonary disease,,"nerve injury or phrenic nerve injury

          5. Multiple trauma

          6. Uncontrolled respiratory disease (severe chronic obstructive pulmonary disease,
             asthma, pulmonary infectio",255573,Chronic obstructive lung disease,TRUE,,,,313299006,Severe chronic obstructive pulmonary disease (disorder),
NCT00642694,chronic obstructive pulmonary disease,,"         information, or evidence at examination; this includes severe sleep apnea, seizure
             disorder, or chronic obstructive pulmonary disease (COPD).

          -  Patient report or evid",255573,Chronic obstructive lung disease,TRUE,,,,13645005,Chronic obstructive lung disease (disorder),
NCT02807675,chronic obstructive pulmonary disease,,"medications to treat orthostatic hypotension (for example droxidopa, fludrocortisone),
             if they have severe dysautonomia

          -  have chronic obstructive pulmonary disease (COPD), as",255573,Chronic obstructive lung disease,TRUE,,,,13645005,Chronic obstructive lung disease (disorder),
NCT02532647,chronic obstructive pulmonary disease,,"               Examples may include poorly controlled diabetes or hypertension, moderate to
                  severe chronic obstructive pulmonary disease, active hepatitis, heart failure or
         ",255573,Chronic obstructive lung disease,TRUE,,,,313299006,Severe chronic obstructive pulmonary disease (disorder),
NCT00671892,allergic rhinitis,,"   -  not an employee working for,or a student under the authority of the PI's

        Exclusion Criteria:

          -  allergic rhinitis past or present

          -  chronic illness resulting in a",257007,Allergic rhinitis,FALSE,,,,61582004,Allergic rhinitis (disorder),
NCT00682643,allergic rhinitis,,"cific IgE (such as RAST, PRIST) will not be allowed for the diagnosis
        of PAR.

        NOTE: Subjects who meet the above criteria and who also may have seasonal allergic rhinitis
        (SAR)",257007,Allergic rhinitis,FALSE,,,,367498001,Seasonal allergic rhinitis (disorder),
NCT00521040,allergic rhinitis,,"ion Criteria:

          -  male or female subjects ≥ 12 years

          -  2 year history of seasonal allergic rhinitis

          -  documented hypersensitivity to local seasonal allergens (grass p",257007,Allergic rhinitis,FALSE,,,,367498001,Seasonal allergic rhinitis (disorder),
NCT02727205,allergic rhinitis,,"        of Day 1 patch application.

         20. Reported a history of anaphylactic reaction to drugs. At the discretion of the
             Investigator, subjects with seasonal allergic rhinitis wit",257007,Allergic rhinitis,FALSE,,,,61582004,Allergic rhinitis (disorder),
NCT04103086,allergic rhinitis,,"   3. Prior history of heart failure.

          4. Prior history of atrial fibrillation.

          5. Prior history of allergic rhinitis, sinusitis, asthma and COPD.

          6. Deafness, mental i",257007,Allergic rhinitis,FALSE,,,,61582004,Allergic rhinitis (disorder),
NCT00239499,allergic rhinitis,,"a:

          -  Patients with significant diseases other than COPD.

          -  Patients with a history of asthma, allergic rhinitis or atopy or who have a total
             blood eosinophil count",257007,Allergic rhinitis,TRUE,,,,61582004,Allergic rhinitis (disorder),
NCT01529229,allergic rhinitis,,"sent of the patient or legal guardian;

          -  Clinical diagnosis of moderate - severe persistent allergic rhinitis according to the
             classification of ARIA (Allergic Rhinitis and It",257007,Allergic rhinitis,TRUE,,,,61582004,Allergic rhinitis (disorder),
NCT02953366,allergic rhinitis,,"     -  Signed Consent of the patient;

          -  Clinical diagnosis of moderate - severe persistent allergic rhinitis according to ARIA
             classification(Allergic Rhinitis and Its Impact",257007,Allergic rhinitis,TRUE,,,,61582004,Allergic rhinitis (disorder),
NCT01101022,allergic rhinitis,,"     ideation.

          3. The subject has a body mass index (BMI) of <18.5 or ≥40.

          4. Subject has a concurrent chronic or acute illness (such as severe allergic rhinitis or
             ",257007,Allergic rhinitis,TRUE,,,,61582004,Allergic rhinitis (disorder),
NCT02746042,allergic rhinitis,,"ate to severe co-morbid asthma, including allergic asthma

          5. Cystic fibrosis

          6. Perennial (e.g. patients with clinical symptoms of allergic rhinitis against house
             du",257007,Allergic rhinitis,TRUE,,,,61582004,Allergic rhinitis (disorder),
NCT01848769,exacerbation of asthma,,"ses of cardiovascular, renal or liver disease

          -  Known hypersensitivity to the active treatments

          -  Exacerbation of asthma symptoms within the previous 4 weeks

          -  Inab",257581,Exacerbation of asthma,FALSE,,,,281239006,Exacerbation of asthma (disorder),
NCT00521040,exacerbation of asthma,,"l allergens (grass pollen)

          -  documented pollen-induced asthma

          -  without acute ongoing exacerbation of asthma or allergic rhinitis

          -  no continuous ongoing treatment ",257581,Exacerbation of asthma,FALSE,,,,708038006,Acute exacerbation of asthma (disorder),
NCT01087515,exacerbation of asthma,,"thin the range 19-32 kg/m²

        Exclusion Criteria:

          -  History of lower respiratory tract infection and /or exacerbation of asthma within
             four weeks prior to the informed c",257581,Exacerbation of asthma,FALSE,,,,281239006,Exacerbation of asthma (disorder),
NCT00493090,exacerbation of asthma,,"         -  Using in excess of twelve beta2 agonists during a twelve month period and/or
             experiencing an acute exacerbation of asthma requiring oral steroids in the last 12
             m",257581,Exacerbation of asthma,FALSE,,,,708038006,Acute exacerbation of asthma (disorder),
NCT00748306,exacerbation of asthma,,"          Hypertension at screening is defined as persistent systolic BP >150 mmHg or diastolic
             BP > 90mmHg.

          4. Respiratory tract infection and/or exacerbation of asthma within",257581,Exacerbation of asthma,FALSE,,,,281239006,Exacerbation of asthma (disorder),
NCT01290874,exacerbation of asthma,,"         5. Pregnancy or lactation or an unwillingness to maintain effective birth control.

          6. History of a significant exacerbation of asthma or respiratory tract infection in the
        ",257581,Exacerbation of asthma,TRUE,,,,281239006,Exacerbation of asthma (disorder),
NCT00839124,exacerbation of asthma,,"     a person of moderate or severe persistent asthma as outlined in the current NHLBI
             guidelines for diagnosis and management of asthma.

          -  Exacerbation of asthma more than 2x",257581,Exacerbation of asthma,TRUE,,,,281239006,Exacerbation of asthma (disorder),
NCT00448851,exacerbation of asthma,," a person of moderate or severe persistent asthma as outlined in the current NHLBI
             guidelines for diagnosis and management of asthma.

         15. Exacerbation of asthma more than 2x/wee",257581,Exacerbation of asthma,TRUE,,,,281239006,Exacerbation of asthma (disorder),
NCT00839189,exacerbation of asthma,,"son of moderate or severe persistent asthma as outlined in the current NHLBI
             guidelines for diagnosis and management of asthma.

          -  Exacerbation of asthma more than 2x/week whic",257581,Exacerbation of asthma,TRUE,,,,281239006,Exacerbation of asthma (disorder),
NCT00287378,exacerbation of asthma,,"           a person of moderate or severe persistent asthma as outlined in the current NHLBI
             guidelines for diagnosis and management of asthma.

          -  Exacerbation of asthma more t",257581,Exacerbation of asthma,TRUE,,,,281239006,Exacerbation of asthma (disorder),
NCT03032757,hypertension,,"s such as: heart disease , metabolic disease such as phenylketonuria,
        rheumatoid arthritis, uncontrolled hypertension, poor lung function, or any health
        condition that might put the pa",316866,Hypertensive disorder,FALSE,,,,38341003,"Hypertensive disorder, systemic arterial (disorder)",
NCT02047656,hypertension,," to 80 years of age
             inclusive.

          -  Patients with mild-to-moderate uncomplicated essential hypertension

        Exclusion Criteria:

        Part 1

          -  History of hype",316866,Hypertensive disorder,FALSE,,,,38341003,"Hypertensive disorder, systemic arterial (disorder)",
NCT00375401,hypertension,," or = 30 kg/m2; > or = to 27 kg/m2 for those with
             obesity-related comorbidities including hypertension and dyslipidemia

        Exclusion Criteria:

          -  Pregnancy

          -  ",316866,Hypertensive disorder,FALSE,,,,38341003,"Hypertensive disorder, systemic arterial (disorder)",
NCT03865615,high blood pressure,,"ory, and/or physical exam performed
             or reviewed by the study physician.

          -  Severely low blood (< 90/50) pressure or uncontrolled high blood pressure (>160/100).

          -  S",316866,Hypertensive disorder,FALSE,,,,38341003,"Hypertensive disorder, systemic arterial (disorder)",
NCT00003928,hypertension,,"ine no greater than 1.5 mg/dL OR

          -  Creatinine clearance at least 60 mL/min

        Cardiovascular:

          -  No uncontrolled hypertension

          -  No myocardial infarction within",316866,Hypertensive disorder,FALSE,,,,38341003,"Hypertensive disorder, systemic arterial (disorder)",
NCT03650933,hypertension,,"of grade Ⅲ of Ⅳ
             according to the New York Heart Association(NYHA) system, or occurrence of myocardial
             infarction, unstable arrhythmia, unstable angina or severe hypertension ",316866,Hypertensive disorder,TRUE,,,,843841000000109,Severe hypertension,
NCT00655798,high blood pressure,,"significantly affect the study outcome, including
             diabetes (type 1 or 2) cardiovascular disease and hypothyroidemy

          4. High blood pressure (age <55 y: DBP > 100 or SBP >160 mm H",316866,Hypertensive disorder,TRUE,,,,38341003,"Hypertensive disorder, systemic arterial (disorder)",
NCT02801201,hypertension,,"gic contraindications:

          -  infection at the puncture site, systemic infection or severe sepsis

          -  intracranial hypertension

          -  uncompensated heart failure

          - ",316866,Hypertensive disorder,TRUE,,,,68267002,Benign intracranial hypertension (disorder),
NCT03882424,hypertension,,"pants on anticoagulant drugs, anemic or with known bleeding diatheses.

          -  Participants with a history of severe, uncontrolled hypertension, heart disease,
             cerebrovascular incid",316866,Hypertensive disorder,TRUE,,,,38341003,"Hypertensive disorder, systemic arterial (disorder)",
NCT03197623,hypertension,,"       ability to participate for the duration of the study, such as clinically significant
             cardiovascular disease, uncontrollable hypertension, uncontrolled asthma, symptomatic
         ",316866,Hypertensive disorder,TRUE,,,,38341003,"Hypertensive disorder, systemic arterial (disorder)",
NCT01779895,asthma,,"consent

        Exclusion Criteria:

          -  Anemia

          -  Allergy to any food or medication

          -  Asthma

          -  Family history of congenital immunodeficiency or chronic co",317009,Asthma,FALSE,,,,195967001,Asthma (disorder),
NCT00584636,asthma,,"teria:

        Patient is between the ages of 2 and 8

          -  Has previously been diagnosed with asthma by any physician

          -  Has presented to the ED with an asthma exacerbation judged",317009,Asthma,FALSE,,,,195967001,Asthma (disorder),
NCT03895411,bronchial asthma,,"tive in conventional treatment;

          2. Left ventricular ejection fraction (LVEF) ≤ 50%;

          3. Suffering from bronchial asthma;

          4. Resting sinus heart rate (HR) in newborns <9",317009,Asthma,FALSE,,,,195967001,Asthma (disorder),
NCT03396445,asthma,,"             (i.e., with use of disease-modifying agents, corticosteroids, or immunosuppressive
             drugs) except vitiligo or resolved childhood asthma/atopy.

          -  Known human immuno",317009,Asthma,FALSE,,,,233678006,Childhood asthma (disorder),
NCT02936817,asthma,,"ect who has undergone major surgery within 12 weeks of Visit 1 or has planned to
             undergo a major surgery before the end of the study.

         22. Subject with diagnosis of asthma.

    ",317009,Asthma,FALSE,,,,195967001,Asthma (disorder),
NCT00075569,asthma,,"standard therapy

        Pulmonary

          -  No significant respiratory disease that is uncontrolled with standard therapy

          -  No history of asthma

        Immunologic

          -  HI",317009,Asthma,TRUE,,,,195967001,Asthma (disorder),
NCT00895102,asthma,,"cancer (except basal cell carcinoma);

          -  clinically significant cardiovascular, respiratory (except mild asthma), renal,
             gastrointestinal, hematologic, neurologic, thyroid, or ",317009,Asthma,TRUE,,,,370218001,Mild asthma (disorder),
NCT01425281,asthma,," and/or has known immunosuppressive or
             autoimmune disease (e.g. human immunodeficiency virus, systemic lupus erythematosus,
             rheumatoid arthritis, severe asthma requiring immu",317009,Asthma,TRUE,,,,370221004,Severe asthma,
NCT00463567,asthma,,"ry disease, pulmonary tuberculosis, or clinically
             significant bronchiectasis

          -  Patients with a history of asthma (with further criteria)

          -  Patients with Type I or ",317009,Asthma,TRUE,,,,195967001,Asthma (disorder),
NCT02614274,asthma,,"had a significant injury to the target joint within the past 12 months.

          4. Subject plans to have knee surgery in the next 2 months.

          5. Subject has had an asthma attack, hives, or",317009,Asthma,TRUE,,,,708038006,Asthma attack,
NCT00548184,cardiomyopathy,,"traceptive method in women of
             child-bearing potential.

          -  Severe underlying chronic illness or disease.

          -  Cardiomyopathy or baseline LVEF less than 50%.

          ",321319,Cardiomyopathy,FALSE,,,,85898001,Cardiomyopathy (disorder),
NCT01031290,cardiomyopathy,,"er, schizophrenia, bipolar disorder, mania,
        or hypomania

        vii) History of myocardial infarction, angina, congestive heart failure, cardiomyopathy,
        stroke or transient ischemic ",321319,Cardiomyopathy,FALSE,,,,85898001,Cardiomyopathy (disorder),
NCT03057548,cardiomyopathy,,"tients with any corrected or uncorrected congenital heart disease

          -  Patients with a history of hypertrophic cardiomyopathy

          -  Patients with cardiomyopathy and a left ventricular",321319,Cardiomyopathy,FALSE,,,,233873004,Hypertrophic cardiomyopathy (disorder),
NCT01212094,cardiomyopathy,," risk of harm or
        prevent the patient from completing the study (such as, but not limited to cerebrovascular
        disease, ischemic cardiomyopathy, clotting disorder, brittle diabetes, neuro",321319,Cardiomyopathy,FALSE,,,,194849004,Ischemic cardiomyopathy,
NCT01092325,cardiomyopathy,," and 85
             years of age

          -  Have chronic Systolic HF due to primary/idiopathic dilated cardiomyopathy, coronary
             artery disease or hypertension, and stable for at least",321319,Cardiomyopathy,FALSE,,,,53043001,Primary idiopathic dilated cardiomyopathy (disorder),
NCT03065140,cardiomyopathy,,"    -  Presence of other significant concomitant heart diseases such as ischaemic, valvular,
             pericardial heart disease or cardiomyopathy, skeletal muscle disorders

          -  Healthy v",321319,Cardiomyopathy,TRUE,,,,85898001,Cardiomyopathy (disorder),
NCT00230230,cardiomyopathy,,"s
             participation in the study. In particular, diabetics, uncontrolled hypertensives, and
             subjects with clinically significant cardiomyopathy, prostatic hypertrophy, glaucoma,
",321319,Cardiomyopathy,TRUE,,,,85898001,Cardiomyopathy (disorder),
NCT02508623,cardiomyopathy,,"          -  significant coronary artery disease (angina NYHA III/IV), congestive heart failure
             (NYHA III/IV), relevant cardiomyopathy, history of myocardial infarct within the last
     ",321319,Cardiomyopathy,TRUE,,,,85898001,Cardiomyopathy (disorder),
NCT01416974,cardiomyopathy,,"hmia or unexplained syncope, not
             believed to be vasovagal in nature or due to dehydration

          -  History of severe non-ischemic cardiomyopathy with EF ≤20%

          -  Patients w",321319,Cardiomyopathy,TRUE,,,,85898001,Cardiomyopathy (disorder),
NCT00079443,cardiomyopathy,,"tributed to agents used in the study

          -  Impaired cardiac function: history of life threatening arrhythmias, MI within the
             preceding 6 months, severe CAD, cardiomyopathy, conges",321319,Cardiomyopathy,TRUE,,,,85898001,Cardiomyopathy (disorder),
NCT01718600,encephalopathy,,"tion.

          -  Patient has acute illness or unstable chronic illness (e.g. uncontrolled hypertension,
             hepatic encephalopathy, portal hypertension, ascites, and esophageal varices,
  ",372887,Disorder of brain,FALSE,,,,13920009,Hepatic encephalopathy (disorder),
NCT02564198,encephalopathy,,"lcers, fistulas or
             abscesses

          -  Active or recent history of hypertensive crisis or hypertensive encephalopathy

          -  Active non-healing wound or bone fracture

        ",372887,Disorder of brain,FALSE,,,,50490005,Hypertensive encephalopathy (disorder),
NCT02990312,encephalopathy,,"     2. The following active opportunistic infections: Ongoing chronic infections such as
             progressive multifocal leukoencephalopathy (PML), disseminated cryptococcosis, chronic
          ",372887,Disorder of brain,FALSE,,,,22255007,Progressive multifocal leukoencephalopathy (disorder),
NCT01143246,encephalopathy,,"           an NSAID within the prior month (prescription or over the counter) is acceptable Note:
             Use of short-term (< 2 weeks) oral neomycin for acute encephalopathy is acceptable.

    ",372887,Disorder of brain,FALSE,,,,16561007,Acute anoxic encephalopathy (disorder),
NCT01546909,encephalopathy,,"vaccine components or to a vaccine
             containing the same substances

          -  Known personal history of encephalopathy, seizure disorder or progressive, evolving or
             unstabl",372887,Disorder of brain,FALSE,,,,81308009,Disorder of brain (disorder),
NCT03079167,encephalopathy,,"s than 7.00 OR base deficit greater than or equal to 12.0
                  mmol/L

          -  Moderate to severe encephalopathy, defined between one and six hours after birth by
             one or",372887,Disorder of brain,TRUE,,,,81308009,Disorder of brain (disorder),
NCT04045210,encephalopathy,,"s such as schizophrenia

          -  acute alcohol/substance intoxication or withdrawal

          -  severe metabolic encephalopathy

          -  patients on comfort care

          -  Patients not",372887,Disorder of brain,TRUE,,,,472916000,Toxic and/or metabolic encephalopathy,
NCT00147030,encephalopathy,,"r they meet the neurological
        abnormality entry criteria (B) by trained personnel:

        B. Moderate to severe encephalopathy, consisting of altered state of consciousness
        (lethargy,",372887,Disorder of brain,TRUE,,,,81308009,Disorder of brain (disorder),
NCT01059461,encephalopathy,," of moderate or severe
        HIE collected from his NICU's file. Criteria of neonatal asphyxia and encephalopathy
        according to the American College of Obstetricians and Gynecologist and Amer",372887,Disorder of brain,TRUE,,,,81308009,Disorder of brain (disorder),
NCT02640040,encephalopathy,,"    -  Patients are complicated with mental, neurological disorders (such as hypoxic-ischemic
             encephalopathy, epilepsy and dementia) or significant barriers to growth.

          -  Patie",372887,Disorder of brain,TRUE,,,,703300001,Hypoxic ischemic encephalopathy (disorder),
NCT02612337,sensorineural hearing loss,,"t has experienced active vertigo during the lead-in period.

          -  Subject has documented asymmetric sensorineural hearing loss.

          -  Subject agrees to maintain their current treatment",374366,Sensorineural hearing loss,FALSE,,,,428887009,Asymmetrical sensorineural hearing loss (disorder),
NCT03664674,sensorineural hearing loss,,"t has experienced active vertigo during the lead-in period.

          -  Subject has documented asymmetric sensorineural hearing loss.

          -  Subject agrees to maintain their current treatment",374366,Sensorineural hearing loss,FALSE,,,,428887009,Asymmetrical sensorineural hearing loss (disorder),
NCT03897634,sensorineural hearing loss,,"2. Speak English as their primary language

          3. Normal or corrected to normal vision

          4. Sensorineural hearing loss with pure-tone thresholds 20-85 dB HL at octave frequencies
     ",374366,Sensorineural hearing loss,FALSE,,,,60700002,Sensorineural hearing loss (disorder),
NCT04041700,sensorineural hearing loss,,"onduction thresholds with pure tone average (PTA4; mean of 0.5, 1, 2 and 4 kHz)
             of ≤ 55 dB sensorineural hearing loss.

        OR Subject with single-sided sensorineural deafness who is ",374366,Sensorineural hearing loss,FALSE,,,,60700002,Sensorineural hearing loss (disorder),
NCT01481662,sensorineural hearing loss,,"         -  Age older than 18

          -  Two clinical features of the triad present: encephalopathy, sensorineural hearing loss
             assessed by audiogram, retinal artery occlusion assessed",374366,Sensorineural hearing loss,FALSE,,,,60700002,Sensorineural hearing loss (disorder),
NCT01072409,sensorineural hearing loss,,"e or older at the time of the study.

          -  Postlinguistic onset of bilateral severe-to-profound sensorineural hearing loss

          -  Bilateral severe-to-profound hearing loss that meets cu",374366,Sensorineural hearing loss,TRUE,,,,194424005,"Sensorineural hearing loss, bilateral (disorder)",
NCT00589511,sensorineural hearing loss,,"riteria:

          -  1 year to 17 years, 11 months of age.

          -  Bilateral severe to profound sensorineural hearing loss for those 1 to 2 years of age.
             Severe hearing loss for t",374366,Sensorineural hearing loss,TRUE,,,,194424005,"Sensorineural hearing loss, bilateral (disorder)",
NCT01092910,sensorineural hearing loss,,"tands the audiological test procedures and use of the Esteem System.

          -  Subject has mild to severe sensorineural hearing loss between 500 and 4000 Hz in the
             ear to be implanted",374366,Sensorineural hearing loss,TRUE,,,,898061000000101,Bilateral severe sensorineural hearing loss,
NCT00205881,sensorineural hearing loss,,"rience.

          2. Age 18 years or older.

          3. Postlingual onset of hearing loss.

          4. Sensorineural hearing loss of a severe or greater degree in both ears.

          5. Normal/",374366,Sensorineural hearing loss,TRUE,,,,60700002,Sensorineural hearing loss (disorder),
NCT01975571,sensorineural hearing loss,,"    Criterion for selection will be subject interest in preservation of residual hearing;
        severe sensorineural hearing loss; lack of benefit from appropriately fit binaural hearing
        aid",374366,Sensorineural hearing loss,TRUE,,,,898061000000101,Bilateral severe sensorineural hearing loss,
NCT00107055,eye disorder,," and/or regarding which an ophthalmologist has recommended cataract
                  surgery);

               -  Other vision-impairing disorders (if a subject is aware of any eye disorder that
    ",375252,Disorder of eye,FALSE,,,,371405004,Disorder of eye proper (disorder),
NCT02565537,eye disorder,,"thin corneas.

          -  Patients with topographic evidence of keratoconus.

          -  Patients with ectatic eye disorders.

          -  Patients with autoimmune diseases.

          -  Patient",375252,Disorder of eye,FALSE,,,,371405004,Disorder of eye proper (disorder),
NCT03475147,eye disorder,,"Control

          -  Age matched 18-80 years of age.

          -  Healthy normal controls with no known eye disorders.

        Exclusion Criteria:

          -  Scotoma or any other ocular disorder",375252,Disorder of eye,FALSE,,,,371405004,Disorder of eye proper (disorder),
NCT00861484,eye disorder,,"evant abnormality

          -  History of psychiatric illness or suicidal attempts or behaviours

          -  History of any eye disorder or colour blind, excluding myopia and presbyopia

          ",375252,Disorder of eye,FALSE,,,,371405004,Disorder of eye proper (disorder),
NCT03751202,eye disorder,,"             with the absorption, distribution, metabolism or excretion of the drug.

         17. Use of oral or parenteral corticosteroids in the previous four 4 weeks

         18. Eye disorders es",375252,Disorder of eye,FALSE,,,,371405004,Disorder of eye proper (disorder),
NCT02193217,eye disorder,," significant endocrine, thyroid, hepatic, respiratory, gastrointestinal,
             renal, cardiovascular disease, eye disorder or history of psychiatric/psychotic
             disorder.

          ",375252,Disorder of eye,TRUE,,,,371405004,Disorder of eye proper (disorder),
NCT00170729,eye disorder,,"ye.

          -  Clinically significant trichiasis or other clinically relevant concurrent
             inflammatory/ infective eye disorders (e.g. conjunctivitis, episcleritis) except mild
         ",375252,Disorder of eye,TRUE,,,,128295000,Inflammatory disorder of the eye (disorder),
NCT04045496,eye disorder,,"     5. History or evidence of active infections (Grade ≥2).

          6. History or evidence of significant inflammatory or vascular eye disorder.

          7. History of an allogeneic bone marrow ",375252,Disorder of eye,TRUE,,,,128295000,Inflammatory disorder of the eye (disorder),
NCT01919996,eye disorder,,"itive rapid antigen detection test.

        Exclusion Criteria:

          -  History of clinically significant eye disorder that would interfere with protocol test
             procedures.

        ",375252,Disorder of eye,TRUE,,,,371405004,Disorder of eye proper (disorder),
NCT00892918,eye disorder,,"pterygium or clinical suspected conjunctival tumor.

          3. eye surgery in the last 6 months.

          4. eye disorders: severe dry eye syndrome, ocular surface diseases, glaucoma, recurrent
 ",375252,Disorder of eye,TRUE,,,,371405004,Disorder of eye proper (disorder),
NCT02334683,dystonia,,"on Criteria:

          -  18 years or older

          -  Confirmed diagnosis of focal upper extremity dystonia (FHD) or upper limb spasticity

          -  Stable onabotulinumtoxinA dose regimen wit",375800,Dystonia,FALSE,,,,445006008,Focal dystonia (disorder),
NCT02347579,dystonia,,"otor / Trophic: Reports of decreased range of motion and/or motor
                       dysfunction (weakness, tremor, dystonia) and/or trophic changes (hair, nail,
                       skin)

    ",375800,Dystonia,FALSE,,,,15802004,Dystonia (disorder),
NCT01592110,dystonia,,"nce or history of renal or hepatic insufficiency.

          -  Have known history, hypersensitivity or idiosyncratic reaction (including dystonias)
             to risperidone, paliperidone, and/or a",375800,Dystonia,FALSE,,,,15802004,Dystonia (disorder),
NCT00530790,dystonia,,"ndex,in which case to
             implement polysomnography), etc.

          -  Patients with complication of movement disorder (e.g. Parkinson's disease, dyskinesia,
             dystonia, etc.).

",375800,Dystonia,FALSE,,,,15802004,Dystonia (disorder),
NCT00580658,dystonia,,"
          -  Patients who are diagnosed with chronic, intractable (drug refractory)primary
             dystonia, including generalized and or segmental dystonia, hemidystonia, and cervical
         ",375800,Dystonia,FALSE,,,,15802004,Dystonia (disorder),
NCT03620279,dystonia,,"e spasticity or fixed contracture in the more affected limb that limits
             functional arm and hand use

          -  dystonia

          -  severe visual or auditory disorders that prevent l",375800,Dystonia,TRUE,,,,15802004,Dystonia (disorder),
NCT02671604,dystonia,,"         -  Patients with comorbid diseases that can cause increased muscular activity such as
             severe dystonia or status asthmaticus,

          -  Patients with renal or hepatic failure ",375800,Dystonia,TRUE,,,,15802004,Dystonia (disorder),
NCT01588574,dystonia,,"r female aged 18~75

          -  Have no clinically significant medical condition

          -  Cervical dystonia

        Exclusion Criteria:

          -  Pregnant or lactation

          -  Subjec",375800,Dystonia,TRUE,,,,230322000,Isolated cervical dystonia (disorder),
NCT03921450,dystonia,,"associated with impaired or aberrant
             movement, such as brain tumors, stroke, M. Parkinson, M. Huntington, dystonia, or
             severe head trauma with subsequent loss of consciousnes",375800,Dystonia,TRUE,,,,15802004,Dystonia (disorder),
NCT03704168,dystonia,,"coagulopathies, life threatening
             arrhythmias

          3. Upper respiratory airway obstruction, e.g: severe dystonia

          4. History of previous local surgery

          5. Any con",375800,Dystonia,TRUE,,,,15802004,Dystonia (disorder),
NCT02204839,background diabetic retinopathy,," 50 years.

          -  Suffering from, or diagnosed with a diabetes related complication (apart from mild
             background diabetic retinopathy).

          -  HbA1c >8.5%.

          -  Curr",376683,Nonproliferative diabetic retinopathy,FALSE,,,,390834004,Nonproliferative retinopathy co-occurrent and due to diabetes mellitus (disorder),
NCT02444767,background diabetic retinopathy,,"ion, ocular
             infection, corneal edema). Patients may have mild blepharitis, mild dry eye,
             cataracts, age-related macular degeneration or background diabetic retinopathy if, in",376683,Nonproliferative diabetic retinopathy,FALSE,,,,390834004,Nonproliferative retinopathy co-occurrent and due to diabetes mellitus (disorder),
NCT02208115,background diabetic retinopathy,," 50 years.

          -  Suffering from, or diagnosed with a diabetes related complication (apart from mild
             background diabetic retinopathy).

          -  HbA1c >8.5%.

          -  Curr",376683,Nonproliferative diabetic retinopathy,FALSE,,,,390834004,Nonproliferative retinopathy co-occurrent and due to diabetes mellitus (disorder),
NCT02639507,background diabetic retinopathy,,"sed and
             treated by an endocrinologist, internist or family medicine physician

          -  Background diabetic retinopathy

          -  DME with central subfield thickness (CST) > 325 µ",376683,Nonproliferative diabetic retinopathy,FALSE,,,,390834004,Nonproliferative retinopathy co-occurrent and due to diabetes mellitus (disorder),
NCT00664183,non proliferative diabetic retinopathy,,"s with a history of systemic diabetes (type I or II)

          -  Subject with a documented history of Non Proliferative Diabetic Retinopathy (NPDR)

          -  Subjects with no PVD at baseline exa",376683,Nonproliferative diabetic retinopathy,FALSE,,,,390834004,Nonproliferative retinopathy co-occurrent and due to diabetes mellitus (disorder),
NCT01698749,non proliferative diabetic retinopathy,,"following inclusion
             criteria shall be enrolled in the study:

               1. Patients of Non Proliferative Diabetic retinopathy (NPDR)with clinicaly
                  significant macul",376683,Nonproliferative diabetic retinopathy,TRUE,,,,390834004,Nonproliferative retinopathy co-occurrent and due to diabetes mellitus (disorder),
NCT03475407,non proliferative diabetic retinopathy,,"lling the following inclusion
        criteria shall be enrolled in the study:

          -  Patients of Non Proliferative Diabetic Retinopathy(NPDR) with clinically significant
             macular e",376683,Nonproliferative diabetic retinopathy,TRUE,,,,390834004,Nonproliferative retinopathy co-occurrent and due to diabetes mellitus (disorder),
NCT00352807,background diabetic retinopathy,,"                 severe dry eye). Patients with mild chronic blepharitis, age-related macular
                  degeneration, background diabetic retinopathy may be enrolled at the discretion
        ",376683,Nonproliferative diabetic retinopathy,TRUE,,,,390834004,Nonproliferative retinopathy co-occurrent and due to diabetes mellitus (disorder),
NCT00355446,background diabetic retinopathy,,"on, or severe
             dry eye). Patients with mild chronic blepharitis, age-related macular degeneration,
             background diabetic retinopathy may be enrolled at the discretion of the inv",376683,Nonproliferative diabetic retinopathy,TRUE,,,,390834004,Nonproliferative retinopathy co-occurrent and due to diabetes mellitus (disorder),
NCT01319487,non proliferative diabetic retinopathy,," in at least one eye (""study eye"")
             involving the center of the macula:

          5. Mild to severe non proliferative diabetic retinopathy (Early Treatment Diabetic
             Retinopat",376683,Nonproliferative diabetic retinopathy,TRUE,,,,390834004,Nonproliferative retinopathy co-occurrent and due to diabetes mellitus (disorder),
NCT00382083,hearing impairment,,"or read English or who are unable to complete the consent process or
             questionnaire for reasons such as hearing impairment or other physical or mental
             disabilities

          ",377889,Hearing loss,FALSE,,,,15188001,Hearing loss (disorder),
NCT02901548,hearing loss,,"otential participants with irreversible toxicity that is not reasonably expected to
             be exacerbated by the investigational product may be included (e.g., hearing loss,
             periphe",377889,Hearing loss,FALSE,,,,15188001,Hearing loss (disorder),
NCT03825627,hearing impairment,," implants inside the brain or any electrical medical device (e.g. pacemaker)
             in the body

          -  Visual or hearing impairment, to the extent that it interferes with task instruction",377889,Hearing loss,FALSE,,,,15188001,Hearing loss (disorder),
NCT01332656,hearing impairment,,"t urine) or
             proteinuria >500 mg/24h

          9. Pre-existing peripheral neuropathy > grade 1 according to the NCI CTCAE V.4.03

         10. Pre-existing hearing impairment > grade 1

 ",377889,Hearing loss,FALSE,,,,15188001,Hearing loss (disorder),
NCT02500589,impaired hearing,,"l be excluded:

          -  1.Active diagnosis of psychosis or dementia in their medical records

          -  2.Severely impaired hearing or speech

          -  3.Lack of telephone access

        ",377889,Hearing loss,FALSE,,,,15188001,Hearing loss (disorder),
NCT01499628,hearing impairment,,"      -  Patients who are not fluent in English or are cognitively impaired

          -  Patients with serious hearing impairment

          -  Patients who are hospital inpatients, who are living in",377889,Hearing loss,TRUE,,,,15188001,Hearing loss (disorder),
NCT03907748,hearing impairment,,"riteria:

          -  Dyads where either or both the caregiver or person with dementia have significant
             hearing impairments that are not resolved through the use of a hearing aid device ",377889,Hearing loss,TRUE,,,,15188001,Hearing loss (disorder),
NCT02862379,hearing impairment,,"          -  Persons who gave consent to participate in the study

          -  Persons with severe visual or hearing impairment

        Exclusion Criteria:

          -  Patients with severe disease",377889,Hearing loss,TRUE,,,,15188001,Hearing loss (disorder),
NCT03162328,hearing loss,,"n lesion).

          -  Individuals who self-report severe contact dermatitis or allergy to silicone, nickel
             or silver.

          -  Individuals who self-report moderate hearing loss.

",377889,Hearing loss,TRUE,,,,21451000119101,Mild to moderate hearing loss (disorder),
NCT02590796,hearing impairment,,":

          -  General Wards

               -  Unable to understand spoken task instructions

               -  Vision or hearing impairment severe enough to preclude testing or interview

         ",377889,Hearing loss,TRUE,,,,15188001,Hearing loss (disorder),
NCT03777254,myopia,,"rization (CNV) for any reason other than
             AMD (such as fundus angioid streaks, ocular histoplasmosis, pathologic myopia,
             trauma);

          5. Afferent pupillary defect(APD);",379805,Myopia,FALSE,,,,57190000,Myopia (disorder),
NCT01284309,myopia,,"s (LASIK) or photorefractive keratectomy (PRK) in any eye

          -  Ocular trauma within the past six months

          -  Severe myopia

          -  Diabetes, Type I or Type 2, with or without m",379805,Myopia,FALSE,,,,34187009,Severe myopia (disorder),
NCT02590692,myopia,,"previous 3 months in any clinical trial of a drug by ocular or
             systemic administration (within previous 18 months for sustained release products)

         16. Axial myopia of greater tha",379805,Myopia,FALSE,,,,408757002,Axial myopia (disorder),
NCT03025399,myopia,,"terfere the fundus examination、Non - diabetic
             retinopathy、uveitis、amotio retinae、optic nerve diseases and high myopia with fundus
             lesions et al.)

          2. Combined with ",379805,Myopia,FALSE,,,,34187009,Severe myopia (disorder),
NCT03329638,myopia,,"blyopia or manifest strabismus including intermittent tropia

          -  Ocular disorders that potentially affect myopia or refractive power

          -  Previous or current use of contact lenses, ",379805,Myopia,FALSE,,,,57190000,Myopia (disorder),
NCT03713268,myopia,,"      1. Healthy controls: Healthy eyes without known disease: refractive error including
             myopia and non-significant cataract is allowed. For selected testing pseudophakia is
            ",379805,Myopia,TRUE,,,,57190000,Myopia (disorder),
NCT01335867,myopia,,"reatment with drugs with known retinotoxicity

          8. History of visual field defects or predisposing factors, including glaucoma, severe
             myopia, retinal disorders, cataracts, diabe",379805,Myopia,TRUE,,,,34187009,Severe myopia (disorder),
NCT01705236,myopia,,"            optic neuropathy, active advanced glaucoma, injury of the optic nerve based on the
             ophthalmologist's clinical judgment

         11. history or presence of severe myopia

    ",379805,Myopia,TRUE,,,,34187009,Severe myopia (disorder),
NCT02040298,myopia,,"thalmologic disease / Concomitant ophthalmologic disorders (e.g. diabetes,
             macular degeneration, glaucoma, severe myopia , etc).

          -  Myopia > -7 Diopters (Severe myopia)

      ",379805,Myopia,TRUE,,,,34187009,Severe myopia (disorder),
NCT04063644,myopia,high myopia,"that have not undergone cataract surgery.

          -  Cases that do not accept surgery (weak corneas, high degree of myopia, sensitivity to
             light, severe dryness of the eyes or by their",379805,Myopia,TRUE,severe,high,pre,34187009,Severe myopia (disorder),
NCT02281292,proliferative diabetic retinopathy,," of the study.

          -  Other protocol-defined inclusion criteria may apply.

        Exclusion Criteria:

          -  Proliferative diabetic retinopathy in the study eye, with the exception of ",380096,Proliferative retinopathy with diabetes mellitus,FALSE,,,,59276001,Proliferative retinopathy co-occurrent and due to diabetes mellitus (disorder),
NCT00970723,proliferative diabetic retinopathy,,"DRD, patient under dialysis

          -  Other causes for macular edema (uveitis, epiretinal membrane)

          -  Proliferative diabetic retinopathy requiring panretinal photocoagulation at inclus",380096,Proliferative retinopathy with diabetes mellitus,FALSE,,,,59276001,Proliferative retinopathy co-occurrent and due to diabetes mellitus (disorder),
NCT02294474,proliferative diabetic retinopathy,,"ening visit.

          -  Hospitalization for diabetic ketoacidosis in the last 6 months before screening visit.

          -  Unstable proliferative diabetic retinopathy or any other rapidly progres",380096,Proliferative retinopathy with diabetes mellitus,FALSE,,,,59276001,Proliferative retinopathy co-occurrent and due to diabetes mellitus (disorder),
NCT03547206,proliferative diabetic retinopathy,,"dition that appears consistent with a
             reduction in visual acuity to <20/25, diabetic retinopathy beyond mild
             non-proliferative diabetic retinopathy not involving the macula, ",380096,Proliferative retinopathy with diabetes mellitus,FALSE,,,,390834004,Nonproliferative retinopathy co-occurrent and due to diabetes mellitus (disorder),
NCT03635814,proliferative diabetic retinopathy,,"esolved (e.g., foveal atrophy,
                  abnormal pigmentation, dense subfoveal hard exudate)

               3. Subject who has proliferative diabetic retinopathy.

               4. Subject ",380096,Proliferative retinopathy with diabetes mellitus,FALSE,,,,59276001,Proliferative retinopathy co-occurrent and due to diabetes mellitus (disorder),
NCT02461771,proliferative diabetic retinopathy,,"e study eye including amblyopia, anterior ischemic
             optic neuropathy, clinically significant diabetic macular edema, severe non
             proliferative diabetic retinopathy, or prolifer",380096,Proliferative retinopathy with diabetes mellitus,TRUE,,,,312905005,Severe nonproliferative diabetic retinopathy,
NCT00717457,proliferative diabetic retinopathy,,"ithin the previous 6 months;

          -  evidence of clinically significant diabetic complications;

          -  known proliferative diabetic retinopathy;

          -  myocardial infarction (MI), ",380096,Proliferative retinopathy with diabetes mellitus,TRUE,,,,59276001,Proliferative retinopathy co-occurrent and due to diabetes mellitus (disorder),
NCT01310166,proliferative diabetic retinopathy,," History or presence of malignancy in the last 5 years

          -  Diabetic patients with moderate or severe non-proliferative diabetic retinopathy or
             proliferative diabetic retinopathy",380096,Proliferative retinopathy with diabetes mellitus,TRUE,,,,312905005,Severe nonproliferative diabetic retinopathy,
NCT00060892,proliferative diabetic retinopathy,,"y of malignant neoplasm (clinical, laboratory or imaging), except
             for basal cell carcinoma of the skin.

          -  Subjects who have proliferative diabetic retinopathy or severe, non-p",380096,Proliferative retinopathy with diabetes mellitus,TRUE,,,,59276001,Proliferative retinopathy co-occurrent and due to diabetes mellitus (disorder),
NCT03272451,proliferative diabetic retinopathy,,"ctive bleeding or significant increased risk of bleeding, severe hepatic
             insufficiency, current peptic ulceration, proliferative diabetic retinopathy

          -  Uncontrolled hypertensi",380096,Proliferative retinopathy with diabetes mellitus,TRUE,,,,59276001,Proliferative retinopathy co-occurrent and due to diabetes mellitus (disorder),
NCT01487044,diabetic macular edema,,"ics, with an age of 18 years of older

          -  Vision of 20/40-20/400 in the Study Eye

          -  Diabetic Macular Edema as documented by SD-OCT and Fluorescein Angiogram.

        Exclusion C",380097,Diabetic macular edema,FALSE,,,,312912001,Macular edema due to diabetes mellitus (disorder),
NCT02193945,diabetic macular edema,,"d to:

               -  Neovascular age-related macular degeneration;

               -  Fibrovascular scar;

               -  Diabetic macular edema; and

               -  Proliferative diabetic r",380097,Diabetic macular edema,FALSE,,,,312912001,Macular edema due to diabetes mellitus (disorder),
NCT00050479,diabetic macular edema,,"rimary outcome (artificial tears are permitted).

          9. History of cancer and prognosis of survival of less than 3 years.

         10. Participants whose diabetic macular edema, in the opinion",380097,Diabetic macular edema,FALSE,,,,312912001,Macular edema due to diabetes mellitus (disorder),
NCT02862938,diabetic macular edema,,"is or other ocular inflammatory disease.

         11. Participant is receiving systemic steroids or other immunosuppressive medications.

         12. Participant has diabetic macular edema and/or di",380097,Diabetic macular edema,FALSE,,,,312912001,Macular edema due to diabetes mellitus (disorder),
NCT03505567,diabetic macular edema,,"sease study eye(s)
             at the study visit; and

          -  Subjects diagnosed with retinal pathology including but not limited to: Macular
             Degeneration, Diabetic Macular Edema,",380097,Diabetic macular edema,FALSE,,,,312912001,Macular edema due to diabetes mellitus (disorder),
NCT00656903,diabetic macular edema,,"ely compromise the visual acuity of the study eye including amblyopia,
             anterior ischemic optic neuropathy, clinically significant diabetic macular edema,
             severe non prolifera",380097,Diabetic macular edema,TRUE,severe,significant,pre,312911008,Clinically significant diabetic macular edema,
NCT00473928,diabetic macular edema,,"        compromise the VA of the study eye including amblyopia, anterior ischemic optic
             neuropathy, clinically significant diabetic macular edema, severe non proliferative
             di",380097,Diabetic macular edema,TRUE,severe,significant,pre,312911008,Clinically significant diabetic macular edema,
NCT00387582,diabetic macular edema,," Subjects will be eligible if the following criteria are met:

               -  Clinically significant diabetic macular edema (CSME) or clinically significant
                  diabetic macular edema",380097,Diabetic macular edema,TRUE,severe,significant,pre,312911008,Clinically significant diabetic macular edema,
NCT00403156,diabetic macular edema,,"     could likely compromise the visual acuity of the study eye including amblyopia,
             anterior ischemic optic neuropathy, clinically significant diabetic macular edema,
             severe",380097,Diabetic macular edema,TRUE,severe,significant,pre,312911008,Clinically significant diabetic macular edema,
NCT00815360,diabetic macular edema,,"I or Type II diabetes

        Disease related considerations:

          -  Study eye with clinically significant diabetic macular edema characterized by macular
             edema, peripheral nonper",380097,Diabetic macular edema,TRUE,severe,significant,pre,312911008,Clinically significant diabetic macular edema,
NCT03452475,epilepsy,,"          7. Known hypersensitivity or contraindication to arterolane-piperaquine, DHA-piperaquine,
             artemisinin, mefloquine (epilepsy, major psychiatric illness) or primaquine

          ",380378,Epilepsy,FALSE,,,,84757009,Epilepsy (disorder),
NCT00672659,epilepsy,,"        -  Significant physical illness which would interfere with trial assessments

          -  Reduced hepatic function

          -  Epilepsy

          -  History of cardiac dysrhythmia

       ",380378,Epilepsy,FALSE,,,,84757009,Epilepsy (disorder),
NCT00061399,epilepsy,,"     15 or 3 to 8

          -  No evidence of hypoxic injury

        Exclusion Criteria

          -  History of epilepsy, mental retardation, or documented evidence of developmental
             dy",380378,Epilepsy,FALSE,,,,84757009,Epilepsy (disorder),
NCT01866397,epilepsy,,"ir or probenecid.

          -  An expected survival of less than three days.

          -  Known alcohol dependency, epilepsy, pregnancy or liver failure.

          -  Infection with a ganciclovir o",380378,Epilepsy,FALSE,,,,84757009,Epilepsy (disorder),
NCT02276625,epilepsy,,"     study

          -  (hydroxy)chloroquine or mefloquine use

          -  History of any neurological disorder including epilepsy or febrile seizures

          -  Pregnancy or breastfeeding

    ",380378,Epilepsy,FALSE,,,,84757009,Epilepsy (disorder),
NCT01489267,epilepsy,," impaired individuals

          2. Schizophrenics

          3. Patients with severe kidney and liver disease, epilepsy, heart disease, pulmonary
             disease, cardiac arrhythmia, diabetes in",380378,Epilepsy,TRUE,,,,84757009,Epilepsy (disorder),
NCT01050231,epilepsy,,"ical clips or mechanical devices

          -  Metallic hardware on scalp region

          -  prior diagnosis of seizure and epilepsy

          -  severe migraine headache

          -  currently pr",380378,Epilepsy,TRUE,,,,84757009,Epilepsy (disorder),
NCT01777048,epilepsy,,"992)

          4. Those without written parental consent

          5. Those with brain pathology such as serious head injury, epilepsy, and intellectual
             disability (IQ < 70)

          ",380378,Epilepsy,TRUE,,,,84757009,Epilepsy (disorder),
NCT01319344,epilepsy,," Patients with known cerebrovacular disease

          -  Patients with peripheral occlusive artery disease

          -  Patients with history of epilepsy

          -  Patients with severe hepatic d",380378,Epilepsy,TRUE,,,,84757009,Epilepsy (disorder),
NCT00981383,epilepsy,,"ination < 24)

          -  Other neurologic conditions (Parkinson's disease, Huntington's chorea, history of
             epilepsy, birth trauma, significant traumatic brain injury, clinical stroke,
",380378,Epilepsy,TRUE,,,,84757009,Epilepsy (disorder),
NCT03005704,thrombocytopenia,,"     -  Not taking antiplatelet therapy prior to participation

        Exclusion Criteria:

          -  Known thrombocytopenia, other coagulation disorder such as von Willebrand's disease,
         ",432870,Thrombocytopenic disorder,FALSE,,,,302215000,Thrombocytopenic disorder (disorder),
NCT00923013,thrombocytopenia,,"       -  Neutropenia (ANC less than 1000 cells/microl).

          -  Anemia (Hgb less than 10g/dL).

          -  Thrombocytopenia (Plt less than 100,000/microl).

          -  Absolute lymphocyte c",432870,Thrombocytopenic disorder,FALSE,,,,302215000,Thrombocytopenic disorder (disorder),
NCT00829439,thrombocytopenia,,"Stomach or intestinal ulcers - Kidney disease - Hematological problems, including anemia, leucopenia, and thrombocytopenia - Used investigational drugs/intervent",,Thrombocytopenic disorder,FALSE,,,,302215000,Thrombocytopenic disorder (disorder),
NCT00740090,thrombocytopenia,,"o: systemic lupus
        erythematosus, rheumatoid arthritis, multiple sclerosis, Sjogren's syndrome, or autoimmune
        thrombocytopenia.

        Laboratory evidence of possible autoimmune disea",432870,Thrombocytopenic disorder,FALSE,,,,128091003,Autoimmune thrombocytopenia,
NCT01998789,thrombocytopenia,,"olesterolemia (> 350 mg/dL) or hypertriglyceridemia (> 500 mg/dL) within
             30 days prior to baseline.

          -  Thrombocytopenia (platelets < 50,000/mm3)

          -  Absolute neutroph",432870,Thrombocytopenic disorder,FALSE,,,,302215000,Thrombocytopenic disorder (disorder),
NCT03980548,thrombocytopenia,,"urs.

        -

        Exclusion Criteria:

          1. General exclusion criteria will be a known history of leucopenia, thrombocytopenia, or
             severe hepatic or renal dysfunction, as w",432870,Thrombocytopenic disorder,TRUE,,,,302215000,Thrombocytopenic disorder (disorder),
NCT02074358,thrombocytopenia,," 2 weeks prior to dosing

          -  History of any severe drug allergy including allergy to Heparin or history of
             Heparin-induced thrombocytopenia, hypersensitivity to PCCs or Factor X",432870,Thrombocytopenic disorder,TRUE,,,,73397007,Heparin-induced thrombocytopenia (disorder),
NCT03786757,thrombocytopenia,,"Clinically significant gastrointestinal bleeding within 12 months before
                  randomization;

               4. Thrombocytopenia, unknown severe anemia at screening or pre-randomization;
",432870,Thrombocytopenic disorder,TRUE,,,,302215000,Thrombocytopenic disorder (disorder),
NCT03887026,thrombocytopenia,,"BV), or hepatitis C (HCV)
             antibody screen

          -  Any clinically significant abnormal laboratory or ECG test. Presence of
             thrombocytopenia at screening is exclusionary
",432870,Thrombocytopenic disorder,TRUE,,,,302215000,Thrombocytopenic disorder (disorder),
NCT02387723,thrombocytopenia,,"1 L/min, moderate to
             severe claudication or morbid obesity

          6. Clinical significant anaemia, leukopenia, leukocytosis or thrombocytopenia

          7. Clinically significant ab",432870,Thrombocytopenic disorder,TRUE,,,,302215000,Thrombocytopenic disorder (disorder),
NCT03014908,obesity,obesity,"riteria:

          -  aged between 8 and 18

          -  normal-weight according to the International Obesity Task Force (IOTF) BMI criteria

          -  fasted for at least 8 hours.

        Exclu",433736,Obesity,FALSE,,,,414916001,Obesity (disorder),
NCT00800852,obesity,,"nclusion Criteria:

          -  children with Prader-willi syndrome

          -  children with simple obesity

        Exclusion Criteria:

          -  subjects with diabetes mellitus (fasting plas",433736,Obesity,FALSE,,,,415530009,Simple obesity (disorder),
NCT01920672,obesity,,"mal pressure hydrocephalus, Parkinson's disease, advanced
             heart failure (New York Heart Stage 3-4), morbid obesity (BMI > 35), and indications
             of restless legs syndrome or pe",433736,Obesity,FALSE,,,,238136002,Morbid obesity (disorder),
NCT03136835,obesity,,"/ comfort care

          -  Normal exclusions for MRI (e.g. claustrophobia, cardiac pacemaker, etc.)

          -  Obesity

          -  Infections/ anemia

          -  Smoker

          -  Serious ",433736,Obesity,FALSE,,,,414916001,Obesity (disorder),
NCT01814735,adiposity,,"t circumference ≥ 90cm if male and ≥ 80cm if female (India-specific cutpoints for
             abdominal adiposity)

          3. Daily rice consumption (≥200grams/day, > ~2cups/day) as determined by ",433736,Obesity,FALSE,,,,414916001,Obesity (disorder),
NCT04050969,obesity,," lipids unachievable with diet and
                  maximum doses of lipid lowering medications).

               -  Obesity-induced cardiomyopathy.

               -  Clinically significant obstruct",433736,Obesity,TRUE,,,,414916001,Obesity (disorder),
NCT00654381,obesity,,"patic function

          3. History of severe allergy/hypersensitivity

          4. Treatment with anti-diabetic, anti obesity drugs, etc 3 months before Visit 1

          5. Fasting blood glucose ",433736,Obesity,TRUE,,,,414916001,Obesity (disorder),
NCT01872754,obesity,,"atient considered ""full stomach"": Diabetes with
                  autonomic dysfunction, severe gastroesophageal reflux, severe obesity and morbid
                  hiatal hernia and any other situati",433736,Obesity,TRUE,,,,83911000119104,Severe obesity (disorder),
NCT02430558,obesity,,"ul symptoms (subjective IKDC < 65,
                  no improvement for 3 months)

               -  No significant obesity (BMI < 30)

               -  Accompanying ligamentous and meniscal lesions,",433736,Obesity,TRUE,,,,414916001,Obesity (disorder),
NCT02116335,obesity,," than 16 kg/m2 (severely and very severely underweight) or that is
             greater than 40 kg/m2 (Class III obesity)

          -  Having evidence of cardiovascular, pulmonary, renal, hepatic, ce",433736,Obesity,TRUE,,,,414916001,Obesity (disorder),
NCT02345018,hemophilia a,,"on

          9. Coagulant disorders or increased risk for thrombo-embolic complications: known
             coagulant disorders such as hemophilia A, hemophilia B, Von Willebrand disease,
           ",434007,Hereditary factor VIII deficiency disease,FALSE,,,,28293008,Hereditary factor VIII deficiency disease (disorder),
NCT02718677,hemophilia a,,"clinically documented during a 6 months period] and
             without inhibitors) male subjects with hemophilia A receiving routine prophylaxis
             treatment.

          2. Age:

         ",434007,Hereditary factor VIII deficiency disease,FALSE,,,,28293008,Hereditary factor VIII deficiency disease (disorder),
NCT01891461,hemophilia a,,"          -  Participation in any other pharmaceutical or clinical investigation

               -  Bleeding disorders (Hemophilia A, Hemophilia B, Von Willebrand disease, factor
                  VII",434007,Hereditary factor VIII deficiency disease,FALSE,,,,28293008,Hereditary factor VIII deficiency disease (disorder),
NCT02585635,haemophilia a,,"sion Criteria:

          -  People will be eligible to participate in the family survey if they have haemophilia A
             or B and are aged between 14 and 17 years, or if they are the parent of",434007,Hereditary factor VIII deficiency disease,FALSE,,,,28293008,Hereditary factor VIII deficiency disease (disorder),
NCT04055051,hemophilia a,,"ollowing inclusion criteria are eligible for
        enrollment into the study:

          1. Congenital hemophilia A or B of any severity, who have and have not undergone a liver
             transpl",434007,Hereditary factor VIII deficiency disease,FALSE,,,,28293008,Hereditary factor VIII deficiency disease (disorder),
NCT00916032,hemophilia a,,"ening

          -  Participant has provided signed informed consent

          -  Participant has severe hemophilia A, defined by a baseline FVIII level < 1% of normal,
             as tested at scre",434007,Hereditary factor VIII deficiency disease,TRUE,,,,16872008,Severe hemophilia A,
NCT03741881,haemophilia a,," time of signing informed consent.

          -  Severe (FVIII [factor 8] activity less than 1%) congenital haemophilia A or severe
             (FIX [factor 9] activity less than 1%) congenital haemo",434007,Hereditary factor VIII deficiency disease,TRUE,,,,16872008,Severe hemophilia A,
NCT02615691,hemophilia a,,"855 or
             plasma transfusion at any time prior to screening

          3. Participant has severe hemophilia A (Factor VIII (FVIII) < 1%) as determined by the
             central laboratory,",434007,Hereditary factor VIII deficiency disease,TRUE,,,,16872008,Severe hemophilia A,
NCT00759655,hemophilia a,,"usion Criteria:

          -  Male patients less than 6 years of age with moderately severe to severe hemophilia A
             (FVIII less than or equal to 2%).

          -  Treatment history of les",434007,Hereditary factor VIII deficiency disease,TRUE,,,,16872008,Severe hemophilia A,
NCT02137850,haemophilia a,,"-  Male, age below 6 years of age at the time of signing informed consent

          -  Diagnosis of severe haemophilia A (FVIII activity level 1%) based on medical records
             or central lab",434007,Hereditary factor VIII deficiency disease,TRUE,,,,16872008,Severe hemophilia A,
NCT02216630,alcohol dependence,," study results

          -  Subjects on chronic immunosuppressive or chemotherapeutic therapy

          -  Known drug or alcohol dependence or any other factors which will interfere with the
       ",435243,Alcohol dependence,FALSE,,,,66590003,Alcohol dependence (disorder),
NCT03659305,alcohol dependence,,"urgical procedures including appendectomy in the last 12 weeks prior to the
             signing of the informed consent.

          -  History of drug or alcohol dependence - regular intake of more t",435243,Alcohol dependence,FALSE,,,,66590003,Alcohol dependence (disorder),
NCT02623205,alcohol dependence,,"ppliances, or presence of shrapnel.

          9. Bipolar Disorder

         10. Lifetime history of psychosis

         11. Current drug or alcohol dependence or abuse (excluding nicotine) - within 6",435243,Alcohol dependence,FALSE,,,,66590003,Alcohol dependence (disorder),
NCT00592254,alcohol dependence,,"actation

          5. Subjects with a known recent history (within the past 6 months) of illicit drug or
             alcohol dependence

          6. Sensory difficulties such as deafness or blindne",435243,Alcohol dependence,FALSE,,,,66590003,Alcohol dependence (disorder),
NCT02643264,alcohol dependence,,"        1. Age 18 - 65

          2. Current Diagnostic and Statistical Manual (DSM-IV-TR) diagnosis of alcohol dependence

          3. Alcohol use in the past month

          4. Right handed (self-",435243,Alcohol dependence,FALSE,,,,66590003,Alcohol dependence (disorder),
NCT03595293,alcohol dependence,,"ment Center residential patients with alcohol use disorder, moderate to
             severe (equivalent to Alcohol Dependence in DSM-IV-TR), or prescription opioid use
             disorder (pOUD)

  ",435243,Alcohol dependence,TRUE,,,,66590003,Alcohol dependence (disorder),
NCT01420211,alcohol dependence,,"diseases which could affect drug metabolism or elimination

          -  history of any serious psychological disorder

          -  drug or alcohol dependence

          -  positive drug or alcohol s",435243,Alcohol dependence,TRUE,,,,66590003,Alcohol dependence (disorder),
NCT00535002,alcohol dependence,,"    dependence, this would seriously compromise the feasibility of recruitment.
             Individuals with alcohol dependence will be excluded. However because of the high
             comorbidity ",435243,Alcohol dependence,TRUE,,,,66590003,Alcohol dependence (disorder),
NCT02836067,alcohol dependence,,". Spirometry criteria FEV1/FVC < 0.7 (definition of COPD) and GOLD (severe-very severe)
             Stage 3 or 4 within past 12 months

          9. A history of alcohol dependence within the 6 month",435243,Alcohol dependence,TRUE,,,,66590003,Alcohol dependence (disorder),
NCT02728063,chronic alcoholism,,"c, pulmonary,
             hepatic, renal, hematologic, neoplastic, or infectious);

          -  With acute or severe chronic disease (chronic alcoholism, drug addiction) found
             incompati",435243,Alcohol dependence,TRUE,,,,66590003,Alcohol dependence (disorder),
NCT02410720,dehydration,," clearance <30 mL/minute)

          -  Severe congestive heart failure (New York Heart Association [NYHA] class III or IV)

          -  Dehydration

          -  Laxative use or dependency

        ",435796,Dehydration,FALSE,,,,34095006,Dehydration (disorder),
NCT01724801,dehydration,," of liver metastases,
        or < 5 x ULN in case of liver metastases.

        The symptoms of increased intracranial pressure are uncontrolled after dehydration and
        cortisone treatment.

  ",435796,Dehydration,FALSE,,,,34095006,Dehydration (disorder),
NCT00683982,dehydration,,"le for rotavirus test

        Exclusion Criteria:

          -  Severe malnourishment

          -  Severe dehydration

          -  History of diarrhea more than 3 days previous hospitalization

   ",435796,Dehydration,FALSE,,,,450316000,Severe dehydration (disorder),
NCT00120744,dehydration,,"ious and non-bloody vomiting within 4 hours of triage

          -  Diarrhea

          -  Mild to moderate dehydration

        Exclusion Criteria:

          -  Weight less than 8 kilograms

       ",435796,Dehydration,FALSE,,,,34095006,Dehydration (disorder),
NCT01992900,dehydration,," height <70% of the median National Center
             for Health Statistics(NCHS)/WHO reference).

          -  Severe vomiting or dehydration.

          -  Presence of jaundice.

          -  Know",435796,Dehydration,FALSE,,,,450316000,Severe dehydration (disorder),
NCT03452306,dehydration,,"orm.

          -  ECG or vital signs abnormalities (clinically significant).

          -  Positive testing for alcohol, drugs, pregnancy.

          -  Dehydration due to diarrhea, vomiting, or othe",435796,Dehydration,TRUE,,,,34095006,Dehydration (disorder),
NCT00267293,dehydration,,"ellitis, renal dysfunction, hepatic dysfunction, or
             thrombocytopenia.

          -  Presence of moderate or severe dehydration.

          -  Inclusion in the trial on 3 previous occasion",435796,Dehydration,TRUE,,,,450316000,Severe dehydration (disorder),
NCT01755559,dehydration,," (i.e. measles,
             acute lower respiratory tract infection, otitis media, tonsillitis, abscess, severe
             diarrhoea with dehydration, etc.)

          -  History of a full treatmen",435796,Dehydration,TRUE,,,,34095006,Dehydration (disorder),
NCT01715207,dehydration,,"cipients

          8. Elevation of serum creatinine during follow-up (> 30% than baseline)

          9. Diarrhea, resulting severe dehydration

         10. Development of gout or ureter stone

    ",435796,Dehydration,TRUE,,,,450316000,Severe dehydration (disorder),
NCT04041791,dehydration,," first-line antibiotics
             for severe pneumonia such as readmission or meningitis

          -  Shock due to dehydration or severe dehydration (based on WHO definitions (5))
             req",435796,Dehydration,TRUE,,,,450316000,Severe dehydration (disorder),
NCT03304392,psychosis,,"gh suicide risk

          -  suicide attempt or hospitalization in the last year

          -  primary problems with psychosis, alcohol or drug problems, mania

          -  currently receiving activ",436073,Psychotic disorder,FALSE,,,,69322001,Psychotic disorder (disorder),
NCT02793856,psychosis,,"anticoagulation

          -  Blood-borne infectious disease, e.g. hepatitis B

          -  History of mandatory custody because of psychosis or other psychological disease
             inappropriate",436073,Psychotic disorder,FALSE,,,,69322001,Psychotic disorder (disorder),
NCT03567356,psychosis,,"usion Criteria:

          -  LFTs > 5x ULN

          -  Psychiatric or medical instability (eg suicidality, psychosis. Sickle Cell disease
             with frequent crises, etc) that would preclude",436073,Psychotic disorder,FALSE,,,,69322001,Psychotic disorder (disorder),
NCT03661125,psychosis,,"         clinical assessments.

          -  Refuses to be withdrawn from quetiapine (see section 4.7).

          -  Has a family history of psychosis in a first degree relative

          -  Has poo",436073,Psychotic disorder,FALSE,,,,69322001,Psychotic disorder (disorder),
NCT02293057,psychosis,,"rovider (as determined through referral partner);

          3. observable cognitive or developmental delays or active psychosis that would interfere
             with completing consent, assessment o",436073,Psychotic disorder,FALSE,,,,69322001,Psychotic disorder (disorder),
NCT03396367,psychotic disorder,," communicate in English

        Exclusion Criteria:

          -  Unstable, serious psychiatric symptoms (assessed by the Psychotic Disorder subsection
             of the Structured Clinical Intervi",436073,Psychotic disorder,TRUE,,,,69322001,Psychotic disorder (disorder),
NCT04094922,psychotic disorder,,"one able to run PTSD Coach app

        Exclusion Criteria:

          -  Positive screening for bipolar disorder, psychotic disorder, ongoing substance
             disorder, or severe suicidality ac",436073,Psychotic disorder,TRUE,,,,69322001,Psychotic disorder (disorder),
NCT02641028,psychotic disorder,,", assessment or
             treatment in any significant fashion

          3. Any lifetime history of bipolar I, II; schizophrenia or any other psychotic disorders;
             personality disorder",436073,Psychotic disorder,TRUE,,,,69322001,Psychotic disorder (disorder),
NCT03509844,psychotic disorder,,"   PTSD in International Classification of Diseases (ICD-11)

        Exclusion Criteria:

          -  severe psychotic disorder

          -  dissociative identity disorder (DID)

          -  activ",436073,Psychotic disorder,TRUE,,,,69322001,Psychotic disorder (disorder),
NCT01716325,psychosis,,"bile phone

          -  No internet access

          -  Known hospitalization for severe psychiatric disorders (schizophrenia, psychosis)

          -  Known history of eating disorders (anorexia, b",436073,Psychotic disorder,TRUE,,,,69322001,Psychotic disorder (disorder),
NCT01948908,developmental delay,,"blood) that cannot be readily
             cleared

          -  Inability to speak English or Spanish

          -  Developmental delay, psychiatric illness, neurologic impairment, or altered mental
",436077,Developmental delay,FALSE,,,,248290002,Developmental delay (disorder),
NCT01354028,developmental delay,,"le and/or unable to be moved from the infant warmer

          -  Severe congenital anomalies likely to be associated with developmental delay

          -  Apgar score of ≤ 3 at 5 minutes of age

   ",436077,Developmental delay,FALSE,,,,248290002,Developmental delay (disorder),
NCT03675321,developmental delay,,"ition that may explain symptoms

          -  Taking a medication that may explain symptoms

          -  Significant developmental delays

          -  Patients treated with a new drug affecting the ",436077,Developmental delay,FALSE,,,,248290002,Developmental delay (disorder),
NCT01267136,developmental delay,," consistency.

        Exclusion Criteria:

          -  Child cannot self-assess pain due to conditions such as developmental delays,
             chromosomal abnormalities, and other syndromes.

   ",436077,Developmental delay,FALSE,,,,248290002,Developmental delay (disorder),
NCT02344784,developmental delay,,"eriment.

        Exclusion Criteria:

          1. Autism.

          2. Chronic neurological diseases.

          3. Developmental delay.

          4. Psychotic or major effective disorder (psychot",436077,Developmental delay,FALSE,,,,248290002,Developmental delay (disorder),
NCT02515383,developmental delay,,"physician, that would preclude
             participation in the study.

          2. Diagnosis of active psychosis, developmental delay, or severe cognitive impairment as
             determined by p",436077,Developmental delay,TRUE,,,,248290002,Developmental delay (disorder),
NCT00763243,developmental delay,,"and language competence to complete basic word and
             sentence repetition tasks,

          -  no significant developmental delay or neurological condition that, in the opinion of
          ",436077,Developmental delay,TRUE,,,,248290002,Developmental delay (disorder),
NCT02223650,developmental delay,,"s, or central retina

          -  Gestational age ≥ 32 weeks

          -  Birth weight > 1500 grams

          -  No Down syndrome or cerebral palsy

          -  No severe developmental delay which",436077,Developmental delay,TRUE,,,,248290002,Developmental delay (disorder),
NCT03786224,developmental delay,," for outpatient level of
             care, in the opinion of the investigator.

        Exclusion Criteria:

        - Any severe developmental delays (including, but not limited to, Autism Spectrum ",436077,Developmental delay,TRUE,,,,248290002,Developmental delay (disorder),
NCT03134950,developmental delay,,"           Inflammatory Bowel Diseases such as Ulcerative Colitis and Chron's Disease)

          -  documented developmental delay, severe cognitive impairment, or a thought disorder

          -  ev",436077,Developmental delay,TRUE,,,,248290002,Developmental delay (disorder),
NCT00940693,bipolar disorder,,"aceptive methods

          -  Suicide or homicide risk

          -  Organic brain syndrome

          -  Any diagnosis of lifetime bipolar disorder or psychotic disorder, and any actual
            ",436665,Bipolar disorder,FALSE,,,,13746004,Bipolar disorder (disorder),
NCT03406702,bipolar disorder,,"r myoclonic seizures are eligible for the study.

          3. Inadequately treated psychotic or mood disorder (e.g., schizophrenia, major
             depression, bipolar disorder).

          4. Pre",436665,Bipolar disorder,FALSE,,,,13746004,Bipolar disorder (disorder),
NCT03913975,bipolar disorder,,"thy female athlete

        Exclusion Criteria:

          -  Any psychiatric disorder, e.g., depression, bipolar disorder, schizophrenic disorder,
             etc. as determined by clinical evaluati",436665,Bipolar disorder,FALSE,,,,13746004,Bipolar disorder (disorder),
NCT02358343,bipolar disorder,,"depressant drugs;

          3. Evidence of cognitive impairment on Mini-Cog;

          4. Present or past psychosis or bipolar disorder I or II on the MINI;

          5. Alcohol or substance abuse ",436665,Bipolar disorder,FALSE,,,,13746004,Bipolar disorder (disorder),
NCT00223639,bipolar disorder,,"c interview using the Structured Clinical Interview for DSM-IV.

          -  Acute or chronic organic brain syndrome, schizophrenia, bipolar disorder, or any
             psychotic disorder.

       ",436665,Bipolar disorder,FALSE,,,,13746004,Bipolar disorder (disorder),
NCT03884933,bipolar disorder,,"ed on Deslespaul's
        conceptualisation of SMI:

          1. meets criteria for (and presence of) bipolar disorder, severe major depression,
             schizophrenia, schizophreniform, and sch",436665,Bipolar disorder,TRUE,,,,13746004,Bipolar disorder (disorder),
NCT03043261,bipolar disorder,,"dy
             participation (assessment, online interactive learning)

          -  History or presence of psychoses, bipolar disorder, and/or severe personality
             disorders as evaluated ",436665,Bipolar disorder,TRUE,,,,13746004,Bipolar disorder (disorder),
NCT00926588,bipolar disorder,," do not speak English;

          -  have moderately severe cognitive impairment;

          -  have schizophrenia, bipolar disorder, or other psychosis;

          -  are actively suicidal;

        ",436665,Bipolar disorder,TRUE,,,,13746004,Bipolar disorder (disorder),
NCT03706001,bipolar disorder,,"     -  Combine with any type of malignant tumor;

          -  Combine with other serious mental illnesses such as bipolar disorder, schizophrenia,
             schizophrenia-like illness, severe dem",436665,Bipolar disorder,TRUE,,,,13746004,Bipolar disorder (disorder),
NCT02037022,bipolar disorder,," of age or older

        Exclusion Criteria:

          -  Current or lifetime diagnosis of severe psychiatric disorder, such as bipolar disorder

          -  Receiving in-home Applied Behavior Anal",436665,Bipolar disorder,TRUE,,,,13746004,Bipolar disorder (disorder),
NCT04139876,bleeding,,"usion Criteria:

          -  The patient has Grade III-IV haemorrhoids or Grade II haemorrhoids with bleeding
             resistant to rubber band ligation or sclerotherapy

          -  The patient",437312,Bleeding,FALSE,,,,51551000,Bleeding hemorrhoids (disorder),
NCT01994902,bleeding,,"rtical hormone) systemically or locally in the peristomal area.

          5. Currently suffering from peristomal skin problems i.e. bleeding or broken (weeping)
             skin.

          6. Are c",437312,Bleeding,FALSE,,,,50960005,Hemorrhage (morphologic abnormality),
NCT00563758,bleeding,,"een performed
             within the past 5 years. In addition, there should not be history or evidence of
             weight loss, anemia or rectal bleeding since the evaluation was performed.

   ",437312,Bleeding,FALSE,,,,12063002,Rectal hemorrhage (disorder),
NCT00396292,bleeding,,"ion to oral or IV iron (VIT-45)

          -  Documented history of discontinuing oral iron

          -  Significant bleeding

          -  History of anemia other that iron deficiency anemia

      ",437312,Bleeding,FALSE,,,,50960005,Hemorrhage (morphologic abnormality),
NCT03707639,bleeding,," ≥3 months. With normal electrocardiogram results and no history of
        congestive heart failure.

        Without bleeding and thrombosis disease. With normal coagulation function: activated
    ",437312,Bleeding,FALSE,,,,50960005,Hemorrhage (morphologic abnormality),
NCT00502086,bleeding,," related to severe
             liver failure (hepatic encephalopathy, hepatorenal syndrome, gastrointestinal
             bleeding, serum bilirubin level greater than 5 mg/dL, international normalize",437312,Bleeding,TRUE,,,,74474003,Gastrointestinal hemorrhage (disorder),
NCT00597402,bleeding,,"infarction within 6 months

          -  History of stroke within 6 months

          -  Clinically significant peripheral vascular disease

          -  Evidence of bleeding diathesis

          -  C",437312,Bleeding,TRUE,,,,64779008,Blood coagulation disorder (disorder),
NCT00003107,hemorrhage,,"ed hyper or hypothyroidism No Cushing's disease
        Gastrointestinal: No clinically significant gastrointestinal hemorrhages No uncontrolled
        peptic ulcer disease No history of inflammatory",437312,Bleeding,TRUE,,,,74474003,Gastrointestinal hemorrhage (disorder),
NCT01100879,bleeding,," g/L.

          -  Known chronic renal failure, glomerular filtration rate <30 mL/min/m2.

          -  Recent (within last 4 weeks) significant bleeding/surgery, defined as drop in Hb of ≥2
        ",437312,Bleeding,TRUE,,,,50960005,Hemorrhage (morphologic abnormality),
NCT01800240,bleeding,,"          -  History of significant blood loss due to any reason, including blood donation in the
             past 3 months.

          -  History of pre-existing bleeding disorder.

          -  Exi",437312,Bleeding,TRUE,,,,50960005,Hemorrhage (morphologic abnormality),
NCT00962845,malaria,,"systemic lupus erythematosus

          -  No concurrent disease-modifying anti-rheumatic drugs

          -  No concurrent hydroxychloroquine for treatment or prophylaxis of malaria

          -  No ",438067,Malaria,FALSE,,,,61462000,Malaria (disorder),
NCT02511353,malaria,,"iteria:

          -  Symptomatic, uncomplicated Plasmodium falciparum infection

          -  Positive malaria microscopy or malaria RDT (pLDH)

          -  Age: 18-50 years

          -  Provide wr",438067,Malaria,FALSE,,,,61462000,Malaria (disorder),
NCT02859350,malaria,,"lunteers, parents or legal representatives and relevant assent for children
             participants as applicable.

          -  Free from malaria parasitemia by blood smear at enrollment and by PCR",438067,Malaria,FALSE,,,,61462000,Malaria (disorder),
NCT01107145,malaria,," or mixed infection/ parasitemia (P. vivax and
             another species of Plasmodium, i.e. P. vivax, P. ovale, or P. malariae)

          -  History of allergy or hypersensitivity to intervention",438067,Malaria,FALSE,,,,61462000,Malaria (disorder),
NCT02004574,malaria,,"tus on
             the treatment area

         19. Planned initiation of, or changes to, concomitant medication that could affect
             psoriasis vulgaris (e.g. beta blockers, anti-malarials,",438067,Malaria,FALSE,,,,61462000,Malaria (disorder),
NCT02535767,malaria,,"R2000 G6PD qualitative test

        Exclusion Criteria:

          -  Moderate to severe anemia (Hb < 10 g/dL)

          -  Malaria infection by blood smear

          -  Individuals with known posi",438067,Malaria,TRUE,,,,61462000,Malaria (disorder),
NCT01758159,malaria,," last 4 months

        Exclusion Criteria:

          -  With severe anemia (Hemoglobin < 50g/L)

          -  Malaria test positive with Immuno-chromatographic test (ICT)

          -  Mothers/ Care",438067,Malaria,TRUE,,,,61462000,Malaria (disorder),
NCT00386750,malaria,,"f fever (temperature ≥ 37.5°C)

        Exclusion Criteria

          -  Signs/symptoms of severe/complicated malaria

          -  Ingestion of various antimalarial drugs, or antibiotics in the previ",438067,Malaria,TRUE,,,,61462000,Malaria (disorder),
NCT01052584,malaria,,"blood draws and return visits.

        Exclusion Criteria:

          -  General danger signs or symptoms of severe malaria

          -  Signs or symptoms of severe malnutrition, defined as weight-f",438067,Malaria,TRUE,,,,61462000,Malaria (disorder),
NCT01156896,malaria,,";

          -  body weight <65 kg.

        Exclusion Criteria:

          -  presence of severe or complicated malaria as defined by WHO criteria;

          -  clinical evidence of ill health or a ",438067,Malaria,TRUE,,,,61462000,Malaria (disorder),
NCT01973114,vertigo,,"and 70dB

          -  Speech discrimination score in silence: No better than 85%

          -  At least three vertigo attacks (lasting ≥ 20 minutes) during the last three months
             prior to",439383,Vertigo,FALSE,,,,399153001,Vertigo (finding),
NCT03089021,vertigo,,"   -  Fibromyalgia pain syndrome.

               -  Previous neck surgery.

               -  Neck pain associate with vertigo caused by vertebrobasilar insufficiency or
                  chronic hea",439383,Vertigo,FALSE,,,,399153001,Vertigo (finding),
NCT00765336,vertigo,,"dietary supplements containing aluminum, calcium, iron, or
             magnesium

          -  History of vestibular incidents including vertigo, lightheadedness, nausea, or
             vomiting wit",439383,Vertigo,FALSE,,,,399153001,Vertigo (finding),
NCT01698086,vertigo,,"us),
             peripheral vestibular disorders (unilateral/bilateral vestibular hypofunction: benign
             positional paroxysmal vertigo, Meniere's disease, acoustic neuroma)

          -  d",439383,Vertigo,FALSE,,,,111541001,Benign paroxysmal positional vertigo (disorder),
NCT00581659,vertigo,,"er implanted within last 6 months

          -  known seizure disorder or epilepsy

          -  Meniere's disease or any inner ear, vertigo, hearing, or balance conditions

          -  known narcole",439383,Vertigo,FALSE,,,,399153001,Vertigo (finding),
NCT00938145,vertigo,,"f this trial.

          -  Patients who exhibit noticeable anxiety and/or claustrophobia or who exhibit severe
             vertigo when they are moved into the MR.

          -  Patients with sickle",439383,Vertigo,TRUE,,,,103298005,Severe vertigo (finding),
NCT02252874,vertigo,,"ing them from
             training

          -  Having self reported vestibular or cerebellar dysfunction, history of vertigo or
             severe hearing loss

          -  Suffering from crippli",439383,Vertigo,TRUE,,,,399153001,Vertigo (finding),
NCT00802893,vertigo,,"eart failure, atrial fibrillation, aortic valve disease,
             bleeding disorders, history of repeated syncope or vertigo, severe GERD, GI ulcer,
             symptomatic coronary or peripheral",439383,Vertigo,TRUE,,,,399153001,Vertigo (finding),
NCT01950312,vertigo,,"n the past three
             years

          -  Hearing loss that coincides with significant, disabling episodes of vertigo

          -  History of allergic or anaphylactic reactions to monoclonal ",439383,Vertigo,TRUE,,,,399153001,Vertigo (finding),
NCT01604408,vertigo,,"the investigator.

        Exclusion Criteria:

          -  Major lower limb pain or neurologic impairment or vestibular vertigo or visual
             impairment that could severely confound measure",439383,Vertigo,TRUE,,,,50438001,Peripheral vertigo (disorder),
NCT02046148,pre-eclampsia,,"
                  College of Obstetricians and Gynecologists guidelines (ACOG Practice Bulletin
                  2013)

               -  Pre-eclampsia or eclampsia as defined by American College of",439393,Pre-eclampsia,FALSE,,,,398254007,Pre-eclampsia (disorder),
NCT01487980,pre-eclampsia,," pregnancy

          2. history of postpartum haemorrhage (PPH)

          3. (gestational) diabetes

          4. pre-eclampsia

          5. abruptio placentae

          6. caesarian section

    ",439393,Pre-eclampsia,FALSE,,,,398254007,Pre-eclampsia (disorder),
NCT02411916,preeclampsia,,"e is polyhydramnios (amniotic fluid index >22 cm).

          -  Presence of acute or chronic renal disease

          -  Presence of preeclampsia

        Of subjects who enter the study, the develop",439393,Pre-eclampsia,FALSE,,,,398254007,Pre-eclampsia (disorder),
NCT01135758,preeclampsia,,"-  Treatment during the last 2 weeks with thyroid hormones and sympathicomimetic drug.

          -  Present or past diagnosis of eclampsia or preeclampsia.

          -  Untreated or insufficiently t",439393,Pre-eclampsia,FALSE,,,,398254007,Pre-eclampsia (disorder),
NCT03055390,preeclampsia,,"     4. Patients with indications of elective caesarean section.

          5. Medical conditions associated with pregnancy e.g. preeclampsia, diabetes mellitus.

          6. Contraindications for hy",439393,Pre-eclampsia,FALSE,,,,398254007,Pre-eclampsia (disorder),
NCT03070795,pre-eclampsia,,"n who require a Cesarean hysterectomy. Women who require a Post-partum hysterectomy.
        Mothers with severe pre-eclampsia. Mothers with sickle cell disease. Mothers with
        pregestational or",439393,Pre-eclampsia,TRUE,,,,398254007,Pre-eclampsia (disorder),
NCT01112891,pre-eclampsia,,"    -  History of previous adverse pregnancy outcome [preterm delivery <37; weeks GA,
             stillbirth, severe pre-eclampsia, eclampsia, HELLP syndrome (hemolytic anemia,
             elevated ",439393,Pre-eclampsia,TRUE,,,,398254007,Pre-eclampsia (disorder),
NCT03793153,preeclampsia,,"   -  Abruptio placenta, and placental abnormalities or accrete syndromes.

          -  Polyhydraminos, macrosomia, or preeclampsia.

          -  History of thromboembolic disorders, or severe anemi",439393,Pre-eclampsia,TRUE,,,,398254007,Pre-eclampsia (disorder),
NCT03360240,preeclampsia,,"r inclusion cases: Patients with pregnancy that starts before the age of 19
             that develops preeclampsia (mild), severe preeclampsia, gestational hypertension and
             eclampsia, th",439393,Pre-eclampsia,TRUE,,,,46764007,Severe pre-eclampsia (disorder),
NCT03824119,preeclampsia,," 20 weeks gestation

          -  Diagnosis of antenatal hypertensive disorder: gestational hypertension, preeclampsia
             without severe features, preeclampsia with severe features, superimp",439393,Pre-eclampsia,TRUE,,,,398254007,Pre-eclampsia (disorder),
NCT03238365,recurrent disease,,"y/paranasal sinuses, 6) unknown primary considered to have resectable
             disease; patients with recurrent disease that is amenable to surgery are eligible

          -  Eastern Cooperative O",440059,Recurrent disease,FALSE,,,,58184002,Recurrent disease (disorder),
NCT03967379,recurrent disease,,"using distress based on the NCCN
             survivorship guidelines

        Exclusion Criteria:

          -  Recurrent disease requiring treatment

          -  Significant uncontrolled psychiatri",440059,Recurrent disease,FALSE,,,,58184002,Recurrent disease (disorder),
NCT03370276,recurrent disease,,"          the first-line therapy. Additionally, patients with persistent disease or
             platinum-refractory recurrent disease may enroll in this study as a first-line
             therapy.

 ",440059,Recurrent disease,FALSE,,,,58184002,Recurrent disease (disorder),
NCT02010606,recurrent disease,,"nd pathology from the resection that qualifies
             the patient for the trial must be consistent with recurrent disease (ie, patients with
             predominantly pseudoprogression or radia",440059,Recurrent disease,FALSE,,,,58184002,Recurrent disease (disorder),
NCT00093626,recurrent disease,,"logically confirmed ovarian epithelial or primary peritoneal carcinoma

               -  Persistent or recurrent disease

          -  Measurable or evaluable disease

               -  Measurable di",440059,Recurrent disease,FALSE,,,,58184002,Recurrent disease (disorder),
NCT01701752,recurrent disease,," for the study.

          -  Women of child-bearing potential

          -  Clinically significant , uncontrolled, current, chronic or recurrent disease, as
             deemed by the Investigator, (",440059,Recurrent disease,TRUE,,,,58184002,Recurrent disease (disorder),
NCT02385630,recurrent disease,,"    7. History of significant food allergy, certain dietary restrictions

          8. Confirmed or suspected residual or recurrent disease after surgery, synchronous or
             metachronous mali",440059,Recurrent disease,TRUE,,,,58184002,Recurrent disease (disorder),
NCT00446849,recurrent disease,,"or severe renal impairment are contra-indicated for treatment
             with mesalamine compounds and are excluded from the study.

         14. Subjects with current or recurrent disease that coul",440059,Recurrent disease,TRUE,,,,58184002,Recurrent disease (disorder),
NCT00585377,recurrent disease,,"        elements are present, in which case the patient is ineligible.

          -  Stage wet IIIB-IV or recurrent disease

          -  No significant hemoptysis (bright red blood< 1/2 teaspoon or m",440059,Recurrent disease,TRUE,,,,58184002,Recurrent disease (disorder),
NCT01754285,recurrent disease,,"ally significant or relevant abnormal medical history, vital sign, physical
             examination, ECG, or laboratory evaluation finding

          8. Current or recurrent disease that could affect",440059,Recurrent disease,TRUE,,,,58184002,Recurrent disease (disorder),
NCT03474276,severe malnutrition,,"         -  Child able to be followed up during at least three months.

        Exclusion Criteria:

          -  Severe malnutrition defined by a mid upper arm circumference < 115 mm OR Weight/Height",440370,Nutritional marasmus,FALSE,,,pre,29740003,Nutritional marasmus (disorder),
NCT02835157,severe malnutrition,,"chronic kidney disease with baseline deranged renal function (eGFR
             < 90 ml/1.73 m2/min)

          -  Severe malnutrition

          -  Children whose parents refuse to give an informed c",440370,Nutritional marasmus,FALSE,,,pre,29740003,Nutritional marasmus (disorder),
NCT01734408,severe malnutrition,,"izures or progressive neurological disease

          -  Family history of congenital or hereditary immunodeficiency

          -  Severe malnutrition or dysgenopathy

          -  Major congenital de",440370,Nutritional marasmus,FALSE,,,pre,29740003,Nutritional marasmus (disorder),
NCT01549288,severe malnutrition,,"    will be obtained to look for inborn error of metabolism.

          -  Children with renal, pulmonary, cardiac or hepatic dysfunction

          -  Severe malnutrition (weight for length and heigh",440370,Nutritional marasmus,FALSE,,,pre,29740003,Nutritional marasmus (disorder),
NCT01399853,severe malnutrition,," history of seizures or progressive neurological disease

          -  Family history of congenital or hereditary immunodeficiency

          -  Severe malnutrition or dysgenopathy

          -  Major",440370,Nutritional marasmus,FALSE,,,pre,29740003,Nutritional marasmus (disorder),
NCT03170401,severe malnutrition,,"t for at least 1 week

        Exclusion Criteria:

          -  Significant chronic organ failure,

          -  severe malnutrition pre-existing prior to ICU admission

          -  not expected to ",440370,Nutritional marasmus,TRUE,,,pre,29740003,Nutritional marasmus (disorder),
NCT01115439,severe malnutrition,,"(WHO)

          -  Mixed or mono-infection with another Plasmodium species detected by microscopy

          -  Presence of severe malnutrition (defined as a child whose growth standard is below -3
 ",440370,Nutritional marasmus,TRUE,,,pre,29740003,Nutritional marasmus (disorder),
NCT04012333,severe malnutrition,,"h nutritional
             risk:

               1. Low (≤25) or High BMI (≥35)

               2. Moderate to severe malnutrition (as defined by local assessments). We will
                  document",440370,Nutritional marasmus,TRUE,,,pre,29740003,Nutritional marasmus (disorder),
NCT01399723,severe malnutrition,,"vere pneumonia

          -  Clinical or laboratory diagnosis of meningitis

          -  Clinical diagnosis of severe malnutrition (marasmus/kwashiorkor)

          -  Clinical or laboratory diagnosi",440370,Nutritional marasmus,TRUE,,,pre,29740003,Nutritional marasmus (disorder),
NCT03427307,severe malnutrition,,"with severe infections, severe heart disease and liver disease, malignancy,
             autoimmune disorders, severe malnutrition, or clinical conditions requiring oral
             nutrition supplem",440370,Nutritional marasmus,TRUE,,,pre,29740003,Nutritional marasmus (disorder),
NCT00326677,depression,,"Inclusion Criteria:

          -  Age 50 or greater

          -  Center for Epidemiological Studies of Depression Scale (CES-D) score of 11 or higher

          -  Folstein Mini-Mental State score of",440383,Depressive disorder,FALSE,,,,35489007,Depressive disorder (disorder),
NCT00352196,depression,,"
             medical condition, substance-induced psychotic disorder,psychotic disorder not
             otherwise specified, major depression with psychotic features, or bipolar disorder.

         ",440383,Depressive disorder,FALSE,severe,major,,370143000,Major depressive disorder (disorder),
NCT02395263,depression,,"(suicide assessment) of the HAMD.

          -  The subject has a current DSM-Ⅳ-TR axisⅠpsychiatric diagnosis other than depression.

          -  When the MADRS score of baseline visit compares with ",440383,Depressive disorder,FALSE,,,,35489007,Depressive disorder (disorder),
NCT00576355,depressed,," bipolar spectrum disorder: type I, type II, or NOS

          -  Currently meets DSM-IV criteria for a depressed, manic, hypomanic, or mixed episode

          -  Youth assent/parental consent to out",440383,Depressive disorder,FALSE,,,,35489007,Depressive disorder (disorder),
NCT02100982,depression,," diabetes, heart
             disease, arthritis, asthma, COPD

          -  positive screen for symptoms of depression and/or anxiety

        Exclusion Criteria:

          -  non-English speakers

",440383,Depressive disorder,FALSE,,,,35489007,Depressive disorder (disorder),
NCT04010149,depression,,"-report (e.g., anxiety disorder,
             ADHD, Parkinson's disease, etc.)

          2. History of diagnosed severe depression (diagnosed pre-injury)

          3. History of epilepsy (diagnosed ",440383,Depressive disorder,TRUE,,,,310497006,Severe depression (disorder),
NCT00000444,depression,,"onality
             disorder.

          -  Unable to participate in protocol due to functional deficits or severe depression.

          -  Suicidal or homicidal ideation.

          -  Current use ",440383,Depressive disorder,TRUE,,,,310497006,Severe depression (disorder),
NCT01329913,depression,," major neurological disorder, or uncontrolled
             clinically significant psychiatric disorder (for example, depression).

          -  Estimated creatinine clearance of ≤70 mL/min.

         ",440383,Depressive disorder,TRUE,,,,35489007,Depressive disorder (disorder),
NCT01128816,depression,,"it unlikely that
             the patient will comply with the study procedures (e.g. alcohol abuse, lack of
             permanent residence, severe depression, disorientation, distant location, or h",440383,Depressive disorder,TRUE,,,,310497006,Severe depression (disorder),
NCT00302367,depression,,"Right handed.

        Exclusion Criteria:

          1. Diagnosis of any psychotic disorder, bipolar disorder, severe depression, severe
             anxiety, or Autism. Subjects with mild mood, oppo",440383,Depressive disorder,TRUE,,,pre,310497006,Severe depression (disorder),
NCT03893097,anxiety disorder,,"ory of, or ongoing, epilepsy or psychiatric illness (I.e. recent history of
             depression, generalized anxiety disorder; history of psychosis, schizophrenia or other
             major psych",442077,Anxiety disorder,FALSE,,,,21897009,Generalized anxiety disorder (disorder),
NCT01237587,anxiety disorder,,"(DSM-IV)
             Axis I condition, currently or within the past year, except major depressive disorder
             (MDD) and/or generalized anxiety disorder (GAD), adjustment disorder or specifi",442077,Anxiety disorder,FALSE,,,,21897009,Generalized anxiety disorder (disorder),
NCT03406845,anxiety disorder,,"is, with depression (Patient Health
             Questionnaire (PHQ-9) score ≥6) and/or anxiety (General Anxiety Disorder-7 (GAD- 7)
             score ≥6).

          -  Normal cognition or Mild Cogn",442077,Anxiety disorder,FALSE,,,,21897009,Generalized anxiety disorder (disorder),
NCT00277654,anxiety disorder,," Fourth Edition (DSM-IV) criteria.

          3. Subjects must have lifetime panic disorder or generalized anxiety disorder (GAD) as
             defined by DSM-IV criteria (except clause ""does not oc",442077,Anxiety disorder,FALSE,,,,21897009,Generalized anxiety disorder (disorder),
NCT01426997,anxiety disorder,,"MMSE)unless otherwise approved by
             principle investigator

          -  meets criteria for schizophrenia (Given overlap of generalized anxiety disorder (GAD)
             with major depres",442077,Anxiety disorder,FALSE,,,,21897009,Generalized anxiety disorder (disorder),
NCT01966705,anxiety disorder,,"     -  A primary diagnosis of severe health anxiety (somatic symptom disorder or illness
             anxiety disorder) according to the Diagnostic and Statistical Manual of Mental
             Disor",442077,Anxiety disorder,TRUE,,,,16265701000119100,Illness anxiety disorder (disorder),
NCT04086342,anxiety disorder,,"ter A or B);

          4. Current moderate or severe major depressive episode, panic disorder, generalized
             anxiety disorder, or post-traumatic stress disorder (PTSD). Traits associated w",442077,Anxiety disorder,TRUE,,,,21897009,Generalized anxiety disorder (disorder),
NCT03478384,anxiety disorder,,"vere, life-threatening, or prognostic unfavorable comorbidities

          9. Pregnancy, lactation

         10. Indication of a severe depression/anxiety disorder at baseline (PHQ 9 Score ≥15 and/or
",442077,Anxiety disorder,TRUE,,,,197480006,Anxiety disorder (disorder),
NCT00550667,anxiety disorder,,", organic
             psychosis, schizotypal personality disorder, bipolar affective disorder, severe
             anxiety disorder(such as OCD, ASD or PTSD) and mental retardation.

          -  In ",442077,Anxiety disorder,TRUE,,,post,197480006,Anxiety disorder (disorder),
NCT00458445,anxiety disorder,,"          (PTSD), psychosis, bipolar illness, severe obsessive compulsive disorder, severe
             depressive or severe anxiety disorder or other symptomatic manifestations that, in the
         ",442077,Anxiety disorder,TRUE,,,post,197480006,Anxiety disorder (disorder),
NCT02074644,lower urinary tract symptoms,,"PSA

          -  Use of a marketed alpha-blocker for LUTS/BPH in the previous 6 months

          -  Severe lower urinary tract symptoms at screening and baseline defined by all the
             foll",443350,Lower urinary tract symptoms,FALSE,,,pre,763101000000106,Severe lower urinary tract symptoms,
NCT03576001,lower urinary tract symptoms,,"ls with a contraindication for androgen use:

               -  History of prostate or breast cancer

               -  Severe lower urinary tract symptoms (IPSS score of > 19)

               -  Pros",443350,Lower urinary tract symptoms,FALSE,,,pre,763101000000106,Severe lower urinary tract symptoms,
NCT00827242,lower urinary tract symptoms,,"ars of age or older with Benign Prostatic Hyperplasia (BPH) also referred to
             as BPH-LUTS [lower urinary tract symptoms] based on the disease diagnostic criteria at
             the start ",443350,Lower urinary tract symptoms,FALSE,,,,307541003,Lower urinary tract symptoms (finding),
NCT01738464,lower urinary tract symptoms,,"tis/painful bladder syndrome (IC/PBS), chronic prostatitis/chronic
             pelvic pain syndrome (CP/CPPS), Lower Urinary Tract Symptoms, Overactive Bladder, or
             Major Depression.

   ",443350,Lower urinary tract symptoms,FALSE,,,,307541003,Lower urinary tract symptoms (finding),
NCT00239161,lower urinary tract symptoms,,"ys) of costovertebral angle pain or tenderness with or
             without fever, and with or without lower urinary tract symptoms (dysuria, frequency,
             urgency). Diabetic women without l",443350,Lower urinary tract symptoms,FALSE,,,,307541003,Lower urinary tract symptoms (finding),
NCT02135341,lower urinary tract symptoms,,"          consent form

        Exclusion Criteria:

          -  Use of antimuscarinic agent and effective in treatment of lower urinary tract symptoms

          -  Patients with severe cardiopulmon",443350,Lower urinary tract symptoms,TRUE,,,,307541003,Lower urinary tract symptoms (finding),
NCT01748370,lower urinary tract symptoms,,"pable prostate nodule or induration

          -  Hematocrit >50%

          -  Untreated severe obstructive sleep apnea

          -  Severe lower urinary tract symptoms

          -  Uncontrolled or",443350,Lower urinary tract symptoms,TRUE,,,pre,763101000000106,Severe lower urinary tract symptoms,
NCT01505075,lower urinary tract symptoms,,"ibility of gold seeds on electronic portal imaging)

          -  large prostate (> 90cm3) on imaging

          -  severe lower urinary tract symptoms (International Prostate Symptom Score >19 or
   ",443350,Lower urinary tract symptoms,TRUE,,,pre,763101000000106,Severe lower urinary tract symptoms,
NCT04032067,lower urinary tract symptoms,,"erplasia

               1. A volume of prostate gland (TRUS) > 30 cc

               2. Moderate to severe lower urinary tract symptoms with IPSS ≥ 13

               3. 5-15 mL/sec of maximum flow r",443350,Lower urinary tract symptoms,TRUE,,,pre,763101000000106,Severe lower urinary tract symptoms,
NCT01657409,lower urinary tract symptoms,,"e hospital.

        Exclusion Criteria:

          -  Use of antimuscarinic agent and effective in treatment of lower urinary tract symptoms

          -  Patients with severe cardiopulmonary disease",443350,Lower urinary tract symptoms,TRUE,,,,307541003,Lower urinary tract symptoms (finding),
NCT01881516,cognitive dysfunction,,"SCLC;

          -  ECOG 3~4;

          -  Pregnant woman;

          -  >65 or <18 years old;

          -  Patients with evidence of any cognitive dysfunction that would limit their abilities
     ",443432,Impaired cognition,FALSE,,,,386806002,Impaired cognition (finding),
NCT02265848,cognitive impairment,,"         3. Subject pain scores >5 on NPRS

        Exclusion Criteria:

          1. Currently diagnosed with cognitive impairment, or exhibits any characteristic, that
             would limit study",443432,Impaired cognition,FALSE,,,,386806002,Impaired cognition (finding),
NCT02051608,cognitive deficit,,"       -  History or presence of systemic autoimmune disorders potentially causing progressive
             neurologic disease with associated cognitive deficits

          -  History of schizophrenia",443432,Impaired cognition,FALSE,,,,386806002,Impaired cognition (finding),
NCT04077541,cognitive dysfunction,,"ne and access to the Internet

        Exclusion Criteria:

          -  Discharged within 24 hours

          -  Cognitive dysfunction and unable to provide formal consent

          -  Severe brain ",443432,Impaired cognition,FALSE,,,,386806002,Impaired cognition (finding),
NCT01301040,cognitive dysfunction,,"ancer diagnosis of the patients to be fit enough to complete
                  the questionnaires

               -  to be French speaking

               -  to be free of any cognitive dysfunction.

",443432,Impaired cognition,FALSE,,,,386806002,Impaired cognition (finding),
NCT00079807,cognitive impairment,,"cologic treatment for 12 weeks prior to
             enrollment

        Exclusion Criteria:

          -  Any significant cognitive impairment or psychosis

          -  Pregnancy or anticipated preg",443432,Impaired cognition,TRUE,,,,386806002,Impaired cognition (finding),
NCT03720821,cognitive impairment,,"          -  Lack of email/lack of basic computer skills

          -  Diagnosed Alzheimer's or documented severe cognitive impairment

          -  Severely impaired vision or color blindness

      ",443432,Impaired cognition,TRUE,,,pre,702956004,Severe cognitive impairment (finding),
NCT00937001,cognitive deficit,,"nown brain lesions, traumatic brain
             injury, cerebrovascular accidents with resultant moderate to severe cognitive deficits
             or ADL dependency, Parkinson's disease, Huntington'",443432,Impaired cognition,TRUE,severe,severe,pre,702956004,Severe cognitive impairment (finding),
NCT00283881,cognitive deficit,,"erebellum or brainstem,

          -  have a history of alcohol or drug abuse or severe language disturbances or serious
             cognitive deficits,

          -  have uncontrolled medical proble",443432,Impaired cognition,TRUE,severe,serious,post,386806002,Impaired cognition (finding),
NCT03393351,cognitive impairment,,"ears

          -  German-speaking

        Exclusion Criteria for participating patients:

          -  severe cognitive impairment

        Inclusion Criteria for participating health care professio",443432,Impaired cognition,TRUE,,,pre,702956004,Severe cognitive impairment (finding),
NCT03178006,acute disease,,"ween 18-24.9 kg / m2 without diabetes or altered glucose tolerance

        Exclusion Criteria:

          -  Acute disease

          -  Chronic pulmonary, cardiovascular, haematological, gastrointes",443883,Acute disease,FALSE,,,,2704003,Acute disease (disorder),
NCT03701438,acute disease,,"ccine including egg and chicken
             protein, or history of hypersensitivity to a previous dose of an influenza vaccine

          -  Acute disease and/or fever at the time of baseline blood d",443883,Acute disease,FALSE,,,,2704003,Acute disease (disorder),
NCT01106092,acute disease,," -  collapse or shock-like state within 48 hours of vaccination,

               -  convulsions with or without fever, occurring within 3 days of vaccination.

          -  Acute disease and/or fever ",443883,Acute disease,FALSE,,,,2704003,Acute disease (disorder),
NCT00001464,acute disease,,"NCLUSION CRITERIA:

        History - good overall health without history of recent (within 3 months) acute disease;

        Physical examination within normal limits;

        Laboratory evaluation;",443883,Acute disease,FALSE,,,,2704003,Acute disease (disorder),
NCT02838914,acute disease,,"up tests and evaluation procedures.

          4. Aged 18-80 years.

        Exclusion Criteria:

          1. With acute diseases, such as acute phase after myocardial infarction (within 3
          ",443883,Acute disease,FALSE,,,,2704003,Acute disease (disorder),
NCT02888418,acute disease,,"r or kidney disease, cardiovascular disease, severe
             hypertension, diabetes, cancer, all kinds of infectious disease and acute disease or
             in acute attack period of chronic dis",443883,Acute disease,TRUE,,,,2704003,Acute disease (disorder),
NCT00287469,acute disease,,"
          -  Major congenital defects or serious chronic illness.

          -  History of any neurologic disorders or seizures.

          -  Acute disease at the time of enrollment. Acute disease w",443883,Acute disease,TRUE,,,,2704003,Acute disease (disorder),
NCT02981836,acute disease,,"Severe malnutrition, congenital malformation, developmental disorders, or serious
             chronic diseases;

          -  Acute disease or acute stage of chronic disease within 7 days prior to st",443883,Acute disease,TRUE,,,,2704003,Acute disease (disorder),
NCT01218308,acute disease,,"ine; or a history of severe adverse
             reaction to a previous influenza vaccine.

          -  Fever at the time of enrolment.

          -  Acute disease at the time of enrolment.

        ",443883,Acute disease,TRUE,,,,2704003,Acute disease (disorder),
NCT02009748,acute disease,,"min/1.73m²

          -  Any disease with an estimated life expectancy below 1 year

          -  Any clinically significant acute disease requiring drug treatment

          -  Anticipated chemothera",443883,Acute disease,TRUE,,,,2704003,Acute disease (disorder),
NCT03679000,genetic disease,,"        -  Congenital azoospermia

               -  Ejaculation dysfunction

               -  Family history of genetic diseases

          4. Acquired diseases

               -  Genitourinary infe",443916,Hereditary disease,FALSE,,,,782964007,Genetic disease (disorder),
NCT02917863,genetic disease,,"    -  Patients with celiac disease, type I diabetes or other known autoimmune diseases

          -  Patients with genetic diseases or syndromes, such as Down, Williams-Beuren, Turner

          -  A",443916,Hereditary disease,FALSE,,,,782964007,Genetic disease (disorder),
NCT01703728,genetic disease,," to the use of gonadotropins or current pregnancy diagnosed by the
             clinician.

          -  Recurrent miscarriages, known genetic disease of one of the partners or indication of
         ",443916,Hereditary disease,FALSE,,,,782964007,Genetic disease (disorder),
NCT02975986,genetic disease,," SPECT/CT, pregnancy, breastfeeding, chronic renal disease (eGFR <
             60 ml/min/1.73m2), proteinuria, genetic diseases of the kidney, inborn defects of
             lipid metabolism, alcohol",443916,Hereditary disease,FALSE,,,,782964007,Genetic disease (disorder),
NCT01925196,hereditary disease,,"tion, such as structural brain or spinal cord disease, metabolic
             diseases, paraneoplastic syndromes, hereditary diseases, infectious diseases,
             peripheral neuropathy or radicu",443916,Hereditary disease,FALSE,,,,32895009,Hereditary disease (disorder),
NCT00635258,genetic disease,,"r hepatitis B and C, human
             immunodeficiency viruses I and II, syphylis, and vaginal infection), genetic disease,
             severe endometriosis or pelvic inflamatory disease

         ",443916,Hereditary disease,TRUE,,,,782964007,Genetic disease (disorder),
NCT00646893,genetic disease,,"nancy;

          -  Prior severe OHSS;

          -  TESA and TESE patients;

          -  Patients carriers of chromosomal or genetic diseases.

          -  Egg donation cycles.

          -  Froze",443916,Hereditary disease,TRUE,,,,782964007,Genetic disease (disorder),
NCT01050075,inherited disease,,"nced any peripheral neuropathy prior to chemotherapy

          -  Patients who have the potential for serious bleeding due to inherited diseases such as
             hemophilia

          -  Patients",443916,Hereditary disease,TRUE,,,,32895009,Hereditary disease (disorder),
NCT00841295,genetic disease,,"lusion Criteria:

          -  Severe associated disorder, with a probable short-term death,

          -  Identified genetic disease,

          -  Polymalformative syndrome, or severe malformation (",443916,Hereditary disease,TRUE,,,,782964007,Genetic disease (disorder),
NCT01469273,genetic disease,,"    -  Severe co-morbidities diseases of the:

               -  Heart

               -  Liver

               -  Kidney

          -  Genetic disease

          -  Other serious associated diseases,",443916,Hereditary disease,TRUE,,,,782964007,Genetic disease (disorder),
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,,,,,,